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The study of molecular containers has accelerated dramatically since the 
1960's. The introduction of cucurbit[n]urils has contributed tremendously and 
continues to contribute to the expansion of the field. Chapter 1 introduces 
cucurbit[n]urils and their molecular recognition properties toward amino acids, 
peptides, and Insulin. Followed by an overview of the history of CB[n] and their 
analogs made with modified glycoluril backbone, solubilizing groups, alkyl arm 
linker, and type of aromatic arms.  
Chapter 2 describes the application of the acyclic CB[n], Calabadion 1 and 2 
for the molecular recognition of amino acids, peptides, and Insulin. The results show 
that 1 and 2 have preferential binding affinity toward aromatic (e.g. H-Phe-NH2) and 
di-cationic (e.g. H-Lys-NH2) amino acid amides.  Electrostatic interactions between 
the tetraanionic 1 and 2 with the amino acid guests (in their N-acetylated, 
  
zwitterionic, or CO-NH2 forms) was demonstrated to dramatically influence the 
strength of the recognition process.  The binding affinity of  1 and 2 toward insulin 
was compared to that of CB[7], respectively (Ka= 1.32 × 105 M-1 for 1, 3.47 × 105 M-1 
for 2, and 5.59 × 105 M-1 for CB[7]) which showed comparable levels of affinity 
between these three hosts. 
 Chapter 3 introduces a new acyclic CB[n] featuring a central glycoluril trimer 
with sulfonated triptycene aromatic sidewalls. It was observed that the binding 
affinity increases as the alkyl chain length of the guest increases. An x-ray crystal 
structure reveals an overall out-of-plane distortion of the aromatic sidewalls and 
intermolecular packing driven by interactions between the external faces of the 
triptycene sidewalls.  Finally, the trimer host was shown to bind strongly to fentanyl 
which suggests potential usage as in vivo reversal agent.  
 In chapter 4, an analog of 1 was synthesized in which the (CH2)3 linking 
group was removed.  This structural change brings the anionic sulfate substituents 
closer to the electrostatically negative ureidyl C=O portals.  We find that this new 
host displays preferential binding affinity toward quaternary ammonium ioins and a 
higher binding affinity toward dications compared to 1. Most impressive are the 
nanomolar binding affinities toward rocuronium and vecuronium which suggests 
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Chapter 1: Introduction to Molecular Containers 
1.1 Introduction to Molecular Recognition 
Supramolecular chemistry also known as "Chemistry beyond molecule" was 
first conceptualized by Prof. Dr. Jean-Marie Lehn.  Prof. Lehn describes 
supramolecular chemistry as the study of intermolecular forces such as non-covalent 
interactions (Hydrogen bonding, ion-dipole interactions, and π-π interactions) 
between molecules that can be used to bring molecular entities together to form a 
supramolecular complex that often exhibit properties that are distinct from their 
molecular components.to form a new complex.1  Underneath the overarching theme 
of supramolecular chemistry, lies multiple conceptual and application areas including 
molecular self-assembly, molecular recognition, molecular interlocking, catalysis, 
drug solubilization and delivery2.  Within the realm of biology, it is clear that many 
biological functions cellular transport, cell-cell communications and enzymatic 
functions are driven by high affinity and high selectivity molecular recognition events 
that are carefully orchestrated in space and time.  The main focus of this dissertation 
is the synthesis and molecular recognition properties of a new class of supramolecular 
hosts known as cucurbit[n]urils (CB[n]) that also exhibit high binding affinity and 
high selectivity in aqueous solution toward hydrophobic ammonium ions.  As the 
target guests we have focused, in part, on those guests that are components of or 
display interesting biological functions. 
Beyond the molecular recognition properties of CB[n]-type hosts lies interest 




Molecular recognition is the specific association of two or more guests driven by non-
covalent interactions including hydrophobic effect, hydrogen bonding, and shape and 
size complementarity, polarity etc.4  Enzymes use two mechanisms for molecular 
recognitions the "lock and key" mechanism and the "induced fit" mechanism5. The 
binding of the substrate to the active site of the enzyme is critical for the efficiency of 
the enzymatic activity. In the lock and key mechanism, the substrate fits precisely in 
the enzyme active site through shape and size complementarity. In the induced fit 
model, the conformation of the substrate and the enzyme changes to simultaneously 
to complement each other in order to induce the binding.  Of major interest to 
supramolecular chemist is the synthesis of molecular artificial receptors able to mimic 
the functioning of enzymes in biological conditions.6 This introduction section 
discusses molecular hosts and their applications with a focus on cucurbit[n]urils, 
acyclic cucurbit[n]uril and its derivatives.  
 
1.2 Introduction to Macrocyclic Hosts 
Macrocyclic receptors are host molecules that are able to bind to and sequester 
smaller molecule typically within a central cavity.  Such macrocyclic receptors are 
often referred to as molecular container compounds because they are able to hold 
onto their guests in much the same way that real-world containers hold onto other 
objects.  The encapsulation of guest molecules within these molecular containers 
results in new entities known as host•guest complexes that can display properties that 
are different from those of the components.  For example, host•guest complexes may 
enhance the solubility of poorly soluble guests, can prolong the lifetime of guests that 




are malodorous, and can even influence the in vitro and in vivo activity of biological 
active guests.7  Of course, the successful creation of such functional systems requires 
the availability of high affinity host systems to effectively sequester the guests.  
Below, I present examples of other popular host systems that are used in these and 
related applications, along with some of the guiding principles in the creation or 
discovery of high affinity host systems. 
The 1987 Nobel Prize in Chemistry was awarded in part to Professor Donald 
J. Cram for his elucidation of the principle of preorganization,8-10 which is one route 
to enables the formation of stable host-guest complexes.  The principle of 
preorganization states that the closer the geometry and solvation of the uncomplexed 
host and uncomplexed guest resemble their host•guest complex the more stable their 
host•guest complex will be.10  Accordingly, a key question in the field of 
supramolecular chemistry and more specifically molecular container chemistry is 
how to generate a preorganized host?  Host•guest complexes generally feature a 













Host  guest complex
Figure I-1.  Illustration of host• guest complexation. a) complexation between a C-
shaped container and a guest. b) complexation between a cyclic shaped container and 
a guest 
 
For example, Figure I-1a shows the geometry of the hypothetic complex 
formed between a roughly spherical guest and an acyclic C-shaped host.  In order to 
assume the C-shaped conformation required for binding the hypothetical acyclic hosts 
typically must restrict many rotational degrees of freedom (e.g. (CH2)n linkers) which 
is energetically costly and thereby reduces the observed free energy of complexation.  
Accordingly, one way to reduce the energetic penalty incurred upon host•guest 
complexation is simply to pay the energetic price of conformational restriction during 
the synthesis by the formation of a macrocyclic host that has fewer conformational 

























Figure I-2. Chemical structure of Spherand and Podand. 
 
A seminal example of the power of preorganization comes from the work of 
Cram who studied the binding of spherand and its acyclic analogue toward Li+ and 
observed a >17 kcal mol-1 decrease in affinity due to the cleavage of a single carbon-
carbon bond (Figure I-2).  Popular examples of macrocyclic host systems also include 
CB[n], cyclodextrins, 4-sulfo-calix[4]arene (Figure I-3).  However, acyclic systems 
are also capable of exhibiting variable degrees of preorganization.  For example, in 
1978 Whitlock, the term "Molecular Tweezers" to refer to a class of acyclic 
molecular receptors with two flat arms, generally aromatic, separated by a more or 
less rigid spacer, that converge on one another and define a pocket for guest 
inclusion.11  The group of Professor Steven Zimmerman has made large contributions 
toward the development of the field of molecular tweezers. Of more direct relevance 
to the work described in this dissertation is the work of Prof. Roeland Nolte and Prof. 
Frank-Gerrit Klaerner on the glycoluril derived molecular clips and benzonorbornene 




molecular tweezers are water soluble, exhibit high binding affinities, and selectivity 
toward arginine and lysine peptide residues up to 104 M-1.12-14 It was further 
demonstrated that they are able to function as inhibitors of amyloid plaque formation 
due to their specific interaction to the lysine residue of the amyloid β protein.13, 15 
Prof. Roeland Nolte’s group developed molecular clips composed of one central 
diphenyl glycoluril ring and two aromatic o-xylylene rings.16 By virtue of the 
conformational preferences of the seven-membered rings connecting the central 
bicyclic glycoluril unit to the aromatic sidewalls, these molecular clips feature a 
binding cleft.  Nolte’s molecular clips are pre-organized despite the lack of a 







Figure I-3. Chemical structures of selected molecular container molecules including 
β-Cyclodextrins, CB[n], 4-sulfo Calix [4] arene, and Klaerners phosphorylated 
molecular tweezers and Nolte's molecular clips. 
 
A brief description of the structures and binding properties of calixarenes, 
cyclodextrins, and various cyclophanes are given below to serve as an introduction to 
the broader field of molecular containers.  Calixarenes are composed of n aromatic 
rings (n = 4 – 8 mainly) – typically phenols – linked in the 2,6-positions (e.g. meta 
linkages) by methylene bridges.17, 18 The synthetic chemistry of calixarenes is 




molecular recognition of cations, anions, and molecular species in organic solvents 
and in water.19, 20 Calixarenes are commercially available and have shown 
applications as ionophores for membrane transport, extractants, stationary phases, 
electrode ionophores and in optical, electrochemical, biological and chemical 
sensors.21  Calixarenes can exist in four different conformational forms, namely the 
cone, partial cone, 1,2-alternate, and 1,3-alternate conformers.  Of highest relevance 
to molecular recognition of molecular guests is the cone conformation which features 
a bowl-shaped hydrophobic cavity.  Of highest relevance to the research described in 
this dissertation is the molecular recognition properties of sulfo calix[4]arene (Figure 
I-3) that displays high solubility in water.  Sulfo calix[4]arene is able to bind to 
hydrophobic molecules in water and particularly hydrophobic cations that benefit 
from ion-ion interactions and the hydrophobic effect upon complexation.  The 
binding affinity of sulfo calix[4]arene toward such hydrophobic cations  in water is 
typically in the range of 104 – 105 M-1 which relatively low selectivity.22  Despite this 
low affinity and selectivity, sulfo calix[4]arene has a variety of biological applications 
including as an in vivo reversal agents for the toxicity of methyl viologen.23, 24  
 Cyclodextrins are another type of widely used and commercially available 
molecular hosts. Cyclodextrins are macrocyclic oligomers composed of n glucose 
rings (α- n = 6, β- n = 7, γ- n= 8) connected by α-1,4-glycosidic bonds.  
Cyclodextrins are cheap, commercially available, nicely soluble in water, and non-
toxic.  Cyclodextrins exhibit molecular recognition properties toward hydrophobic 
cations, anions, and neutral molecules with Ka values up to ≈ 104 M-1.  Cyclodextrins 




catalysis,25, 26 chemical sensors,27 stationary phases for chiral separations,28 and 
supramolecular polymers and materials.29  Cyclodextrins also have a variety of more 
practical everyday uses.  For example hydroxypropyl-β-CD (HP-β-CD) is the active 
ingredient in the household product FebrezeTM where the cyclodextrin serves to 
release a fragrance molecule and take up odorant molecules when sprayed in the air.30  
Cyclodextrins also have a variety of applications in pharmaceutical science.  For 
example, HP-b-CD and sulfobutyl ether b-CD (SBE-CD, CaptisolTM ) are used to 
increase the solubility and thereby formulate for human delivery > $5 billion per year 
of various active pharmaceutical ingredients.31  Precise molecular engineering of γ-
cyclodextrin allowed the creation of Sugammadex (figure I-4) which exhibits 107 M-1 
affinity toward the clinically important neuromuscular blocking agents rocuronium 
and vecuronium.32 Sugammadex is a billion dollar per year drug that is marketed by 
Merck under the trade name BridionTM and is used as a reversal agent for these 














































The other most popular class of molecular container compounds are the 
cyclophanes which are macrocycles composed of aromatic building blocks and come 
in a variety of sizes and shapes.  A complete description of all the different types of 
cyclophanes are beyond the scope of this introduction; the reader is referred to several 
reviews of aspects of this area.33-38 An increasingly popular class of cyclophanes are 
the pillar[n]arenes (Figure I-5) which are composed of n phenylene or arylene units 
which are linked by methylene bridges in the para positions.  The synthetic chemistry 
of pillararenes has rapidly developed in the past decade and pillararenes soluble in 
both organic solvents and water are available.  Pillararenes have been used for a wide 
variety of applications including the purification of gases, membrane transport, 
supramolecular polymers, chemical sensors, and an increasing number of biomedical 
applications.39, 40  Another class of cyclophanes that have drawn intense interest and 
ultimately garnered the 2016 Nobel Prize in Chemistry for the development of 
molecular machines for Professor Fraser Stoddart is the cationic cyclophane known 
as the blue box (Figure I-5).41 By virtue of its cationic viologen walls, the cavity of 
the blue box is highly electron deficient and constitutes a binding site for electron ring 
aromatic rings.  Furthermore, the viologen units are electrochemically active and can 
form the radical cations upon electrochemical reduction.  This change in the 
electronic properties of the aromatic walls changes its molecular recognition 
properties and allows the construction of a variety of molecular devices like 




group has greatly expanded the potential of this system by expanding the aromatic 













n= 5 - 15  
Figure I-5. Chemical structure of Blue box and general structure Pillar[n]arenes 
 
1.3 The Cucurbit[n]uril Family of Molecular Containers 
The molecular containers described above (e.g. calixarenes, cyclodextrins, 
cyclophanes) were constructed from aromatic or sugar building blocks.  An 
alternative building block known as glycoluril (1, Scheme I-1) has also become 
popular in supramolecular chemistry.  Because glycoluril is a bicyclic ring system 
and because it is concave its incorporation into molecular hosts facilitates the 
curvature needed for macrocyclization to cucurbiturils, for the preparation of C-
shaped compounds that form dimeric assemblies by H-bond driven self-assembly,45 
and for the creation of molecular clips.46  In 1905 Prof. Robert Behrend reported the 
condensation reaction of glycoluril with formaldehyde (2 equivalents) in concentrated 
HCl followed by recrystallization from conc. H2SO4 yielded a crystalline substance 




complexes with inorganic salts and dye stuffs (Scheme I-1).47  The structural 
elucidation of the product of Behrend’s reaction would need to wait until 1981 when 
Mock and co-workers structurally characterized it and dubbed it cucurbituril due to its 
resemblance to the segmented geometry of pumpkins which are members of the 
cucurbitaceae family of plants. Subsequently, cucurbituril has been referred to as 
cucurbit[6]uril (CB[6]) because it is composed of six glycoluril units.  When the 
groups of Kim and co-workers and Day and co-workers conducted the cucurbituril 
forming reaction under milder conditions there were able to form and isolate the key 



















































Scheme I-1. Synthesis of CB[n].  
 
The structure of CB[n] molecular containers feature glycoluril monomers 
linked by pairs of methylene bridges.  CB[n] molecular containers are structurally 
rigid, highly symmetric (Dnh), and contain a hydrophobic cavity surrounded by two 
electrostatically negative ureidyl carbonyl portals.  The height of each CB[n] 
homologue is generally 9.1Å however, the volume of the cavity varies with the 
number of glycoluril repeat units. CB[5], the smallest homologue, has a volume of 




of 142Å3 and CB[7] has a large volume of 242Å3 and CB[8] has an even larger 
volume of 367Å3.  The even numbered homologues (CB[6] and CB[8]) have low 
solubility in water (< 100 µM) whereas the odd numbered homologues (CB[5] and 
CB[7]) display higher (> 10 mM) solubility in water.  The synthesis, molecular 
recognition properties, and applications of macrocyclic CB[n] hosts have been the 
subject of more than 2000 publications to date and the reader is referred to various 
authoritative reviews on the subject.47, 49, 53-55  The most unique feature of the 
molecular recognition properties of CB[n] molecular containers is that they exhibit 
remarkably high binding affinities (Ka routinely 106 M-1, often 109 M-1, and even up 
to 1017 M-1 in special cases)55, 56 hydrophobic (di)cations in water (Figure I-6).  This 
remarkably tight binding is attributed to a combination of the ion-dipole interactions 
at each portal and the hydrophobic effect which is enhanced due to the presence of 
high energy waters in the cavity of the uncomplexed CB[n] hosts.55, 57-60  Equally 
importantly, because CB[n] are such selective hosts they often display large changes 
in binding affinity due to changes in pH as well as electrochemical, photochemical, or 
chemical stimuli.50 These unique properties of CB[n] have been harnessed to create 
CB[n] derived functional systems including drug delivery, supramolecular catalysts, 
chemical sensing, and drug solubilization.7, 61-64  Somewhat outside the scope of this 
introduction is the recognition behavior of CB[8] which is large enough to 
encapsulate two aromatic rings simultaneously which has been used by the Kim 




recognition of amino acids, peptides and proteins, and for supramolecular materials 
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Figure I-6. a) Recognition properties of CB[n]. b) Typical alkyl ammonium guests 
for CB[n] 
 
1.3.1 Molecular recognition of cucurbit[n]uril (CB[n]) towards amino acids  
Buschman et al. were the first to perform binding studies of CB[6] with amino 
acids and amino alcohols using isothermal titration calorimetry (ITC) (Table I-1).70, 71 
The study was performed in 50% (v/v) aqueous formic acid at 25˚C with select amino 




There was little change in binding strength despite the difference in size and 
hydrophobicity of the amino acids. It is believed that the amino acids formed 
exclusion complexes at the ureidyl carbonyl portal of CB[6] instead of going inside 
its hydrophobic cavity. However, this study opened the door for further investigations 
of CB[n]s with amino acids. 
 
Table I-1. Thermodynamic parameters for the complexes CB[6] with amino acids.71 
 
Amino acids Ka (M-1) ΔH (kcal•mol-1) TΔS (kcal•mol-1) 
Gly 4.7 × 103 -3.1 1.9 
Ala 1.0 × 103 -1.7 2.4 
Val 1.4 × 103 -1.0 3.2 
Phe 1.4 × 103 -1.6 2.7 
 
Kim et al. demonstrated that CB[8] could simultaneously bind two guests, 
namely methyl viologen (MV) and 2,6-dihydroxynaphthalene (HN).72 Subsequently, 
they also showed that the CB[8]•MV complex was able to bind with the amino acids 
tryptophan (Trp) and tyrosine (Tyr) by the insertion of the aromatic sidechain into the 
remaining cavity to form the CB[8]•MV•amino acid ternary complexes.73 A complete 
study of the binding of CB[8]•MV toward all 20 amino acids was subsequently 
performed by the Urbach group, which revealed the selectivity of CB[8]•MV toward 
Trp, Phe, and Tyr. No binding was observed for the remaining amino acids.74-76 
Urbach and co-workers also studied the influence of overall guest charge on their 
ability to successfully form CB[8]•MV•amino acids complexes (Figure I-7).77  
Postively charged guests 1 and 2 bind more strongly than zwitterionic free amino acid 
Trp, which in turn binds more strongly than negatively charged guests 3 and 4 by at 




ureidyl C=O portal of CB[n] is electrostatically negative and therefore a cation 
binding site; conversely the ureidyl C=O portals of CB[n] reject guests that place 
additional negative charge at the portal.48, 78, 79  Other studies demonstrated that DPT 
or MBBI could be used instead of MV to form a complex with CB[8] which display 
similar binding to Trp but with enhanced optical outputs.61, 80  These studies of CB[8] 
heteroternary complex formation has been most useful in the context of sensing 
applications and electrochemical molecular machines.  In a separate line of inquiry, 
Prof. Kim and Inoue found that CB[8] could bind two equivalents of Trp or Phe on 
their own with binding constants of 6.9 × 107 and 1.1 × 108 M-1 respectively which 
has subsequently been used to promote peptide and protein dimerization as described 
below.74 An elongated CB[6] derivative was able to bind the aromatic amino acids 
including His and the (±)-bis-nor-seco-cucurbit[6]uril host studied in the Isaacs lab 
was found to bind Phe with a XX:1 diastereoselectivity.81, 82  The binding of CB[7] 
toward amino acids was performed by the Kim and Urbach group,59, 83 which 
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Figure I-7. a) Illustration of CB[8]•MV complex. b) Chemical structures of 
tryptophan (Trp) and Trp derivatives.77 c) CB[8] promoted dimerization of Trp and 
Methyl Viologen.4 
 
1.3.2 Molecular recognition of cucurbit[n]urils toward peptides 
Since peptides consist of multiple amino acid residues, molecular recognition 
of peptides adds another layer of challenges and complexity. Peptide contain an 
oligoamide backbone, which can have different structures based on the amino residue 
sequence and have multiple sidechains and charges. Binding studies were performed 
with CB[6] and various dipeptides and tripeptides.70, 71, 84 The binding constants 
ranged from 3.7 × 102 to 1.5 × 103 M-1 concluding the peptides formed exclusion 
complexes with CB[6].84, 85 As previously mentioned, CB[8]•MV forms a stronger 
binding complex with positively charged Trp derivatives. Based on this information it 
was hypothesized that CB[8]•MV would selectively bind to N-terminal Trp in 
peptides due to a combination of N-terminal NH3+•••O=C ion-dipole interactions and 
the hydrophobic effect. A binding study of CB[8]•MV toward a series of tripeptides 
containing Trp residues at the N-terminus, internal position, and  C-terminus were 




synthetic receptor which is capable of sequence specific peptide recognition.77 CB[8] 
has been used in multiple applications such as self-assembled multivalent receptors 











































Figure I-8. a) Structures of CB[7] and b) Illustration of non-covalent interactions 
(ion-dipole interactions and hydrophobic effect) governing the complexation of 
CB[7] and N-terminal phenylalanine.88 
 
In 2006, Kim et al. reported that CB[7] was able to selectively recognize N-
terminal Phe in the context of dipeptides (Figure I-8).88  This study focused on the 
ability of CB[7] to discriminate between different zwitterionic peptides and cationic 
peptides compared to their sequence diastereomers.67, 88  Kim et al., also demonstrated 
that CB[7] had selective binding towards other N-terminal aromatic peptides.88 
 
1.3.3 Molecular recognition of cucurbit[n]urils toward proteins 
The information obtained from the previously mentioned studies demonstrates 




research groups have taken steps toward this goal including the Wang research group, 
that use CB[8] to mediate the binding of a photodynamic therapy sensitizer to bovine 
serum albumin (BSA)89 and  Nau and coworkers, that use CB[7] to enhance the 
fluorescence and binding of a dye (Brilliant Green) to BSA.90 Most importantly, 
however, the Urbach research group has shown that CB[7] exhibits a high, selective 
binding affinity (Ka = 1.5 x 10⁶ M-1) toward the N-terminal phenylalanine residue of 
Insulin (Figure I-6).63 Interestingly, the x-ray crystallographic results show that the N-
terminus needs to unravel slightly to accommodate the CB[7] unit.  By virtue of this 
ability to unwind, Urbach asserts that the N-terminus of proteins constitutes a 
privileged recognition domain.  Subsequently, a collaboration between Urbach and 
Isaacs should that immobilized CB[7] could be used to perform affinity purification 
of proteins (insulin and human growth hormone) from within complex mixtures by a 
catch and release process.63  This preceding sections have shown that CB[n] possess a 
variety of interesting molecular recognition properties and can be used in a variety of 
application areas.  However, CB[n] do possess some limitations including their low 
water solubility and the difficulty of modifying them.  Chapter 2 of this dissertation 
details the molecular recognition properties of two prototypical acyclic CB[n]-type 





Figure I-9. Illustration of N- terminal residue of phenylalanine of insulin binding to 
CB[7].63 
 































Figure I-10. Synthesis of C-shaped glycoluril oligomers 2-6. 
 
The research theme of the Isaacs group is centered around developing an 
understanding of the mechanism of CB[n] formation and using that knowledge to 
create new CB[n]-type receptors with enhanced functions.  As part of these 
mechanistic studies, the Isaacs group isolated methylene bridged glycoluril dimer – 
hexamer (2 – 6) and studied their molecular recognition properties toward 




bound quite nicely to the hydrophobic dications with a loss of only about 100-fold in 
binding affinity relative to macrocyclic CB[6].  Based on this result, the Isaacs group 
realized that acyclic CB[n]-type receptors would retain the essential recognition 
elements of macrocyclic CB[n], but unfortunately, hexamer is not very soluble and 
can undergo decomposition reactions.  Accordingly, the Isaacs groups saw the 
opportunity to create acyclic CB[n]-type receptors to address issues of solubility and 

















































  R = (CH
2)3SO3Na  
Figure I-11. Chemical structures of Calabadion 1 and 2 also known as M1 and M2 
 
Figure I-11 shows that structure of the two prototypical acyclic CB[n]-type 
receptors (M1 and M2) studied extensively by the Isaacs group over the past decade 
for use in biomedical applications.7  The structure of M1 and M2 feature a central 
glycoluril tetramer which gives the molecular an overall C-shape and the ability to 
bind to hydrophobic cations, two terminal aromatic walls which allow it to engage in 




sodium sulfonate groups which dramatically enhance their solubility in water and 
electrostatic interactions with positively charged guests.93, 94 Compared to 
macrocyclic CB[n], M1 (356 mM) and M2 (18 mM) are much more soluble in pure 
water. 
Scheme I-2 shows the convergent building block based synthetic route used to 
prepare the Motor1 host on scales up to 50 grams.  Methylene bridged glycoluril 
dimer is obtained by the condensation of glycoluril with formaldehyde (1 equiv.) in 
HCl.  Subsequently, 2 is allows to undergo controlled condensation with glycoluril 
bis(cyclic ether) in MeSO3H to give glycoluril tetramer 7 as a key glycoluril oligomer 
building block.  Subsequently, 7 reacts with aromatic wall 8 by a double electrophilic 
aromatic substitution process in acidic conditions (Scheme I-2) to yield Motor1.7 A 
related route can be used to synthetize M2 simply by changing the aromatic wall 
building block in the final step.  M1 and M2 can be easily synthesized on large scale 

































































Motor 1  





Due to their high binding affinity, high water solubility, and ease of synthesis, 
M1 and M2 have been used for a multiple applications including as solubilizing 
agents for insoluble drugs, hydrocarbons and carbon nanotubes, reversal agents for 
neuromuscular blocking agents, reversal agents for rat intoxication with 
Methamphetamine, and components of sensor arrays.95-98 Not only do acyclic CB[n]s 
show multiple applications, when compared to other already commercialized host 
molecules they show higher efficiency. Take for example Sugammadex, a type of 
cyclodextrin currently used clinically as a post-surgical reversal agent for rocuronium 
and vecuronium.  M2 binds to Rocuronium and Vecuronium a 100-fold stronger than 
Sugammadex and maintains a high level of discrimination against acetylcholine.97 In 
vivo studies with rats were conducted with M2 confirming their efficiency and 
effectiveness.98 
 
1.5 Acyclic cucurbit[n]uril derivatives  
As described above, the synthesis of M1 and M2 proceeds by a building block 
approach using glycoluril oligomer and aromatic wall building blocks.  The Isaacs 
group is in the process of performing a medicinal chemistry type structure-binding 
affinity optimization of the properties of acyclic CB[n]-type receptors.  Modifications 
to M1 and M2 have been made with the goal of improving binding affinity, water 
solubility, binding selectivity, glycoluril backbone, enhancing aromatic walls π-π 
interactions, and even introduction new properties such as fluorescence.95, 99  The 
following section will focus on four type of modifications made to acyclic CB[n]. 




analogs with different length alkyl linker to sulfonate groups. Third, modifications 
were made using different type of aromatic arms. Fourth, analogs with different 
length glycoluril backbone, notably a trimer glycoluril backbone.  
 
1.5.1. Modification of the solubilizing groups. 
One of the key structural features of the structure of M1 and M2 are the 
(CH2)3SO3- arms which function in part as solubilizing groups.  In order to assess the 
scope of functional groups that would confer high solubility in water of acyclic 
CB[n]-type receptors while maintaining high binding affinity, the Isaacs group 
designed and studied new acyclic CB[n] featuring anionic (SO3ˉ), neutral (OH), and 























9 R = (CH2)2SO3Na,  10
 R = (CH
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Figure I-12. Chemical structures of acyclic CB[n] derivatives with different 
solubilizing groups; 9 (SO3Na), 10 (NH3Cl), and 11 (OH). X-ray crystal structure of 
10 and 11 in self-complexation form and open form.  
 
It was determined that 9 (346 mM) and 10 (250 mM) displayed high solubility 
in water but that 11 (<2.00 mM) with its OH groups displayed insufficient water 
solubility to be considered for use as a solubilizing excipient for insoluble drugs.100, 
101 According to x-ray crystallography all three analogs (9 – 11) assume an overall C-
shape featuring CH-π and π-π interactions between their aromatic walls.  Similar 
geometric features were seen previously for M1 and M2.  In contrast to the behavior 
of Motor1, however, the ammonium solubilizing groups of 10 were found to undergo 
self-complexation with its own C=O portals driven by intramolecular ion-dipole 
interactions (-NH3+•••O=C).  This self-folding of the arms of 10 results in a smaller 




potential use of 10 as a solubilizing agent for insoluble drugs, this lower binding 
affinity dramatically reduces its utility.100  Compound 11 with its OH solubilizing 
groups also displayed self-complexation between the hydroxyl group and the 
carbonyl portal (OH•••O=C) which also reduced guest binding affinity, but not so 
significantly as that of 10.  Interestingly, the x-ray crystal structure of 11 shows two 
different conformations of 10 in the crystal that differ in the degree of curvature of 
the glycoluril oligomer backbone which provides direct evidence of the ability of 
acyclic CB[n] to adapt their shape to accommodate different sized guests.101  The 
binding properties of 9 – 11 toward hydrophobic ammonium ions and three insoluble 
drugs (tamoxifen, 17α-ethynylestradiol, and indomethacin) were determined by 1H 
NMR, UV/vis spectroscopy, and phase solubility diagrams.   It was found that tetra-
anionic host 9 was the superior host for cationic guests compared to the neutral host 
11 or the cationic host 10 which can be understood based on electrostatic interactions 
and the presence of self-folded conformations for 10 and 11 that feature 
intramolecular H-bonds or ion-dipole interactions.  The Isaacs group concluded that 
the SO3- groups are not merely solubilizing groups but also enhance the affinity of 
acyclic CB[n]-type receptors toward cationic guests electrostatically.  Chapter 4 
describes a modification to the solubilizing arms that further enhances binding 
affinity in particular toward dicationic guests. 
 
1.5.2 Modifications of aromatic arms 
The aromatic walls of acyclic CB[n]-type hosts represent one of the key 




studied a number of different aromatic sidewalls including the benzene and 
naphthalene walls of M1 and M2, an isomer of M2 known as Zhang1 (12), and 
methylated and cyclohexane fused versions.102 These ability of these hosts to function 
as solubilizing excipients for insoluble drug molecules was tested by constructing 
phase solubility diagrams.  From this work, the Isaacs group concluded that M1 with 
its high solubility and very good binding affinity is the most general purpose host 
whereas M2 displays highest affinity toward its guests.  By virtue of their aromatic 
sidewalls, acyclic CB[n] have excellent potential to construct fluorescence sensors 
arrays.103-107  A collaboration between the Isaacs Lab and Prof. Anzenbacher showed 
that a mixture of 12 and a naphthyl derivative of CB[6] function as a supramolecular 
sensing array for cancer associated nitrosamines, over-the-counter drugs, and opiates 
and their metabolites.106 In this study, the naphthalene substituted cucurbit[6]uril has 
high affinity and selectivity toward small guests whereas acyclic cucurbit[n]uril 
derivative 12 with its flexible methylene bridged glycoluril backbone functions a 
cross-reactive component of the sensor array. 105  Because of the stimuli responsive 
properties of (acyclic) CB[n] hosts, this sensing array is sensitive to the presence of 
metal ions such as Eu3+, because of its interaction with the carbonyl portals. When a 
guest reduced or removes this interaction between the metal ion and the carbonyl 
portal, a change in fluorescence is observed which further enhances the sensitivity of 
the assay.105, 106  Significantly, such sensors are able to quantify the presence of drugs 
within the urine of with a single fluorescence reading.106 
More recently, inspired by the work of Swager and others,108 the Isaacs 




have been used as building blocks for polymeric material and fluorescent sensor 
applications.109-112 Host 13 features a central glycoluril tetramer unit and 
O(CH2)3SO3Na solubilizing groups which are identical to those of M1 and M2 
(Figure I-13). Host 13 has good water solubility (3.00 mM) due to the sulfonate 
groups. However, the triptycene walls each possess two benzene rings that help 
define the cavity which in theory makes 13 a host that has eight subunits (e.g. 4 
glycolurils and 4 benzene rings) and may create a more voluminous cavity akin to 
CB[8].  Unfortunately, the x-ray crystal structure of 13 showed the presence of 
π−π interactions between the blades of the opposing triptycene walls in a self-
complexed geometry which reduced overall cavity volume. Quite interestingly, 
however, the researchers found that 13 could bind to large guests such as the Fujita 
square and Stoddarts blue box. However, in these cases the intertwined structures of 
the complexes blurred the lines between what molecules constituted the host and 
which constituted the guest.  Host 13 also displays changes in fluorescence upon 
13•guest complexation presumably due to changes in orientation between triptycene 
walls and undergoes complete quenching in the presence of electron deficient 
pyridinium guests.108  The triptycene walled acyclic CB[n] is just one example of the 
interesting features and properties that can be observed when modifications are made 
to the original acyclic CB[n].  In Chapter 3 of this thesis I present my work on the 
synthesis and molecular recognition properties of a triptycene walled glycoluril trimer 
that we hoped would circumvent the issue of cavity self-inclusion and π−π stacking 




















































Figure I-13.  Chemical structure of Zhang 1 12 and triptycene walled acyclic 
cucurbit[n]uril 13.  
 
1.5.3 Modifications of glycoluril backbone 
Whereas supramolecular hosts containing glycoluril monomer46 or methylene 
bridged glycoluril dimer113 have been known for many years, systems based on 
glycoluril trimer are uncommon.  Accordingly, a collaboration between the groups of 




oligomer length on the hosts ability to act as solubilizing excipients for insoluble 
drugs.114  Dr. Laura Gilberg created glycoluril trimer hosts (Trimer Host 1 and Trimer 
Host 2, Figure I-14) analogous to Motor1 and Motor2 using our building block 
approach.  For this purpose, she first condensed glycoluril with dimethyl glycoluril 
bis(cyclic ether) to give methylene bridged glycoluril trimer building block (2, 
Scheme III-1).  Subsequently, a double electrophilic aromatic substitution reaction 
between (2, Scheme III-1) and the appropriate aromatic wall was performed which 
delivered Trimer Host 1 (48%) and Trimer Host 2 (59%) in good yields.114  Trimer 
host 1 and Trimer Host 2 possess good water solubility (102 and 336 mM) but 
possess smaller cavities than the M1 and M2.  The Isaacs group studied the ability of 
Trimer Host 1 and Trimer Host 2 as solubilizing excipients for the insoluble drugs 
camptothecin, ziprasidone, PBS-1086, and b-estradiol by means of phase solubility 
diagrams.  The researchers found that the glycoluril trimers host performed better 
than analogous hosts based on glycoluril monomer or dimer but less well than M1 or 
M2.114  Trimer Host 1 and Trimer Host 2 display lower binding affinity that M1 and 
M2 toward a common guest presumably due to the smaller cavity volume and the 













































Figure I-14. Chemical structures Trimer acyclic CB[n] host 1 and 2 
 
1.5.4 Modifications of alkyl linker on aromatic arms 
A final structural variable of acyclic CB[n] that has been considered by the 
Isaacs lab is the length of the O(CH2)nSO3Na linking group.  Two acyclic CB[n] were 
made, M2C2 and M2C4 with (CH2)n (n=2 and n=4 respectively) and studied in 
comparison to M2 (n = 3) itself (Figure I-14).115  Just like M2 the hydrophobic cavity 
and carbonyl portal of M2C2 and M2C4 allow for the encapsulation of hydrophobic 
cations as good guests. Compared to M2 (water solubility 14 mM), M2C2 and M2C4 
have higher water solubility (68 mM or 196 mM, respectively). It is however, worth 
noting, that M2C4 become a viscous solution as concentration increases. After 
investigation, it was determined that M2C4 forms a gel in the presence of insoluble 
drugs, however, M2C2 was determined increase water solubility of insoluble drugs. 
The slopes of the phase solubility diagrams show that the binding strength of the three 
hosts toward a panel of 15 insoluble drugs generally follows the order: Motor2 > 
M2C2 > M2C4.  Therefore, M2C2 with its higher aqueous solubility has untapped 
potential as a potential solubilizing excipient.  In Chapter 4 of this dissertation I 
present the synthesis and molecular recognition properties of an analogue of M1 
where the O(CH2)nSO3Na alkylene linker has been completed removed and becomes 


























M2C2 R= (CH2)2SO3Na and M2C4
 R=(CH
2)4SO3Na  
Figure I-15. General structure of acyclic CB[n] with 2 or 4 carbon chain alkyl linkers 
 
1.6 conclusion 
This introductory chapter has presented some of the background of the field of 
molecular recognition using molecular containers compounds (e.g. cyclodextrins, 
calixarenes, pillararenes, cyclophanes).  These macrocyclic molecular containers are 
preorganized for binding and therefore display high binding affinity at selectivity.  In 
this thesis, I focus on the molecular recognition properties of molecular containers 
that are acyclic – acyclic CB[n]-type receptors – which have limited degrees of 
freedom and are therefore preorganized and display very good levels of binding 
affinity and selectivity.  The influence of different structural variables (e.g. aromatic 
wall, glycoluril oligomer length, solubilizing group, linker length) on the recognition 
properties of acyclic CB[n]-type receptors conducted prior to my work was reviewed. 
In the three research chapters of this dissertation I study the: 1)  molecular recognition 
properties of Motor 1 and Motor2 toward amino acids, peptides, and insulin in 
comparison to CB[n], 2) the molecular recognition properties of a triptycene walled 
glycoluril trimer, and 3) an analog of Motor 1 whose (CH2)3 linking groups have been 




Chapter 2: Molecular Recognition Properties of Acyclic 
Cucurbit[n]urils Toward Amino Acids, Peptides, and a Protein 
 
The work presented in this chapter was take from Zebaze Ndendjio, S.; and Isaacs, L. 
Molecular recognition properties of acyclic cucurbiturils toward amino acids, 
peptides, and a protein. Supramol. Chem. 2019. This work was entirely done by me. 
2. 1 Introduction. 
The  synthetic  and  supramolecular  chemistry  of  the CB[n] family has 
played a leading role in  the  field  since  the  preparation  of  cucurbit[n]uril  
homologues example,  the  Ka  for  CB[7]•guest  complexes  routinely exceed 106 M-
1, often exceed 109  M-1,  and  in  special cases (e.g. cationic adamantanes and 
diamantanes) can even exceed  1012  M-1 in  water  due  to the combined effects of 
ion–dipole interactions and the hydrophobic (CB[n],  Figure II-1)  at  the  turn  of  the  

































































































Figure II-1. Chemical structures of CB[n] and Calabadions 1 and 2.   
 
CB[n] compounds are powerful receptors for hydrophobic (di)cations in 




which guard entry to a hydrophobic cavity58. For example, the Ka for CB[7]•guest 
complexes routinely exceed 106 M-1, often exceed 109 M-1, and in special cases (e.g. 
cationic adamantanes and diamantanes) can even exceed 1012 M-1 in water due to the 
combined effects of ion–dipole interactions and the hydrophobic effect. 57, 58 In 
addition to high-affinity binding, CB[n]•guest complexes also display high stimuli 
responsiveness (e.g. pH, electrochemistry, photochemistry, competing guest) which 
allows for the use of CB[n] in a variety of applications.50, 53 For example, CB[7]•guest 
binary complexes and CB[8]•guest1•guest2 ternary complexes are used to construct 
molecular switches and machines116, as supramolecular catalysts54, 117, to solubilize, 
protect, sequester, and even create targeted pharmaceuticals118, as components of 
chemical sensors119, 120, and to promote the assembly of supramolecular polymers, 
materials, and frameworks121. CB[n] have also found wide applicability in peptide 
and protein chemistry. For example, in pioneering work, the Urbach group showed 
that CB[8] promotes the cooperative dimerisation of the Phe-Gly-Gly peptide in 
water via formation of the CB[8]•(Phe-Gly-Gly)2  complex with Ka=1.5 x 1011 M-2 4. 
This motif has been capitalized upon by Brunsveld and Liu to promote the 
dimerisation of proteins tagged with N-terminal FGG units and thereby control 
biological functions.122 For example, Brunsveld engineered a split luciferase123 that 
could be reconstituted by addition of CB[8], and similarly CB[8] was found to 
promote the dimerisation of monomeric caspase-9 into the active dimer.124 Scherman 






Figure II-2. Chemical structure of amino acids, amino amides, and N-acetyl amino 
amides used as guests in this study and illustration of the geometries and driving 
forces involved in their complexation with macrocyclic CB[n]. 
 
In a lovely series of papers, Urbach and collaborators demonstrated that the 
N-terminus of peptides and proteins is a privileged site for host complexation due to 
simultaneous ammonium ion and side chain binding (Figure II-2). In particular, they 
found that CB[7] displays a selectivity toward N-terminal Phe over other N-terminal 
residues presumably because they display suboptimal fit for the CB[7] cavity (e.g. 
other aromatic or hydrophobic amino acids may not fully release cavity waters of 
solvation) or because they cannot sterically accommodate N-terminus and cationic 
side chain binding (e.g. Lys, His, Arg). The CB[7]•N-terminal Phe motif was used to 
recognize Insulin in solution and on resin, to determine protease substrate selectivity, 
to impose sequence-specific inhibition on a non-specific protease, and for 











































Isaacs used a monofunctionalised CB[7] derivative to non-covalently PEGylate the 
N-terminal Phe residue of Insulin and thereby prolong its in vivo function.126 
In recent years, the Isaacs group has synthesized and investigated the 
molecular recognition properties of acyclic CB[n]-type receptors that feature a central 
glycoluril oligomer, two terminal aromatic walls, and four sulphonate solubilising 
groups.95 Two prototypical acyclic CB[n] (Calabadion 1 and Calabadion 2) are shown 
in Figure 1 although numerous variants are known.102 The Calabadions retain the 
essential molecular recognition features of CB[n], but because they are acyclic, they 
are able to flex their methylene bridged glycoluril oligomer backbone to 
accommodate more voluminous guests. Additionally, the acyclic structure of the 
Calabadions may allow guest substituents to protrude through the side of the 
host•guest complex rather than through the portals as required for macrocyclic CB[n]. 
The Calabadions have several important biomedical applications including the 
solubilization of insoluble anticancer drugs for in vivo application127, 128, as agents to 
reverse neuromuscular block in vivo62, and most recently to modulate the hyper 
locomotor activity of rats treated with methamphetamine.98 Recently the Ma group 
has been using acyclic CB[n] for acid-sensitive controlled release and bioimaging 
applications.129 By virtue of their aromatic walls, Calabadions undergo changes in 
their UV/Vis and fluorescence properties upon guest binding and have therefore been 
use as sensors for nitrosamines, over-the counter drugs, amino acids, and opioids.105, 
107 Given the ability of CB[7] and CB[8] to interact with peptide N-termini and 
internal residues, protein N-termini, and to promote dimerization and the fact that 




hypothesized that 1 and 2 would perform well in peptide and protein recognition 
perhaps with selectivity that is complementary to that observed for CB[n]. 
2.2 Results and discussion 
This results and discussion section is organized as follows. First, we lay out 
the goals and the hypotheses to be tested in this study. Next, we describe 1H NMR 
investigations of the binding properties of 1 and 2 toward 19 amino acid amides to 
confirm the 1:1 binding stoichiometry and shed light on the geometrical features of 
the complexes. Next, we present the energetics (ΔG, ΔH, ΔS) of binding of 1 and 2 
toward the various amino amides by isothermal titration calorimetry. Subsequently, 
we detail the influence of electrostatics on the energetics of host•guest binding as 
probed through mutation of amino acid to amino acid amide to N-acetyl amino acid 
amide. Next, we present the binding of 1 and 2 toward selected tripeptides to 
delineate the influence of neighboring residues. Finally, we present the results of 
binding of 1 and 2 toward insulin compared to CB[7]. 
2.2.1 Goals of the study 
Macrocyclic CB[7] selectively recognizes peptides that feature an N-terminal 
hydrophobic aromatic residue like Phe or Trp due to a combination of ion–dipole 
interactions and the hydrophobic effect and discriminates against residues containing 
hydrophobic aliphatic side chains, polar neutral side chains, acidic (anionic) side 
chains, and even basic (cationic) side chains.4, 67, 130 The discrimination of CB[7] 
against the residues with cationic side chains (e.g. Lys and Arg) is due to the fact that 




portals without creating steric interactions between the wall of CB[7] and the adjacent 
CONHR group. We hypothesized that acyclic CB[n] 1 and 2 – with their acyclic 
structure – would display higher affinity toward Lys and Arg and because the steric 
constraints of these amino acids might be better accommodated.131 Accordingly, a 
primary goal of the work is the measurement of the binding affinity of 1 and 2 toward 
the amino acid amides which mimics the context of the amino acid in a longer 
peptide. Within this realm, we also sought to compare the peptide recognition 
properties of 1 and 2 which differ in the nature of their aromatic walls, cavity size, 
and presumably their selectivity toward aromatic amino acids in particular. Given the 
ability of CB[8] to bind two residues simultaneously4, 68, we were aware of the 
possibility of similar behavior with 2 (or 1) and were careful to verify the binding 
stoichiometry. Given that 1 and 2 are tetra-anionic in pH 7.4 water whereas CB[7] is 
neutral at this pH we sought, as a secondary goal, to understand the role of 
electrostatics on the molecular recognition properties of 1 and 2 toward amino 
amides, N-acetyl amino amides, and amino acids themselves. Finally, we wanted to 
examine the recognition properties of 1 or 2 toward N-terminal amino acid in the 
context of a protein (insulin). 
2.3 1H NMR investigations of calabadion•guest binding 
 First, we investigated the binding interactions between 1 and 2 toward amino 
acid amides by 1H NMR spectroscopy. We performed these experiments in 
biologically relevant 20mM sodium phosphate buffered D2O at pD7.4 to ensure 
that the N-terminus of each amino acid amide is present as its NH3+ form which 




Information for 19 amino acid amides (excluding cysteine), we measured 1H NMR 
spectra at different host:guest ratios (generally 1:2, 1:1.5, 1:1, and 1:0.5). We 
monitored the change in guest chemical shifts upon complexation to provide crude 
information on host•guest stoichiometry and to determine whether the kinetics of 
guest exchange is in the fast, intermediate, or slow exchange regime on the 1H NMR 
timescale. Rather than discuss the precise changes for each host•guest complex, we 
discuss here some general trends that are observed in the chemical shifts of both host 
and guest upon complexation. For example, Figure II-3 shows the 1H NMR spectra 
recorded for mixtures of 1 and H-Phe-NH2. A comparison of Figure II-3(a,d) shows 
that the protons on the aromatic ring of H-Phe-NH2 (Hc – He) and the adjacent 
benzylic CH2 group (Hb) undergo a substantial upfield change in chemical shift upon 
complexation (Hc – He; 1–1.5 ppm; Hb ≈ 0.8 ppm) which strongly suggests that the 
Arring and benzylic CH2 of H-Phe-NH2 is bound within the cavity of 1 within the 
1•H-Phe-NH2 complex. Conversely, the α-proton Ha of H-Phe-NH2 undergoes a 
slight downfield shift (≈ 0.2 ppm) upon complex formation which indicates that Hₐ is 
located nearby the deshielding region defined by the ureidyl C = O groups of the host. 
When an excess of H-Phe-NH2 is present (e.g. 1:2, Figure II-3(b)) the resonances for 
Hc – He shift back toward the position observed for uncomplexed H-Phe-NH2 and 
broaden which indicates that this complex displays intermediate exchange kinetics 
on the 1H NMR timescale and likely has 1:1 stoichiometry. In accord with this data 
and based on the known binding preferences of CB[n] and acyclic CB[n], we 




We believe that the amide (C = O)NH2 group of H-Phe-NH2 is hydrogen bonded to 
the ureidyl C=O group of host 1 in the complex.87  
 
Figure II-3. 1H NMR spectra recorded (400 MHz, RT, 20 mM NaH2PO4 buffered 
D2O , pD 7.40) for: a) H-Phe-NH2 (5 mM), (b) 1 (1 mM) and H-Phe-NH2 (2 mM), c) 
1 (1 mM) and H-Phe-NH₂ (1.5 mM), (d) 1 (1 mM) and H-Phe-NH2 (1 mM), e) 1 (1 
mM) and H-Phe-NH2 (0.5 mM), (f) 1 (2 mM). 
 
Related changes are observed during the complexation of the hydrophobic 
amino acid amides (Appendix 1) indicating that side chain cavity inclusion and NH3+ 




resonance for host 1 in the 1•H-Phe-NH2 complex. For example, the Hf protons in 
C2v-symmetric 1 are symmetry equivalent and display a sharp singlet (Figure II-3(f)) 
but become broadened and split upon formation of the C1- symmetric (e.g. no 
symmetry) 1•H-Phe-NH2 complex. This observation can be explained by the fact that 
the chiral host•guest complex renders all four Hf atoms diastereotopic. In the case of 
fast kinetics of exchange, typified beautifully by the 1•H-Leu-NH2 complex, two 
doublets are observed for Hf (Appendix 1, Figure S83). Related observations are 
observed with host 2. None of the complexes between 1 or 2 and the amino acid 
amides displayed slow kinetics of exchange on the 1H NMR timescale. Interestingly, 
for complexes between 1 (2) and the hydrophobic non-aromatic amino acid amides, 
we typically observe a small downfield shift for host aromatic sidewall resonance Hf, 
Ht, Hu (1: up to 0.3 ppm; 2: up to 0.5 ppm).  
 
Figure II-4. (Color online) Schematic illustrations of the geometry of (a) 1•H-Phe-
NH2 and (b) 1•H-Lys-NH2 complexes. 
 
As described previously in related systems, we believe this is due to a 
conformational change that hosts 1 and 2 undergo upon complexation that removes 










































upfield shifting.95 In contrast, for the aromatic amino acid amides (e.g. H-Trp-NH2, 
H-Tyr-NH2, H-Phe-NH2) only very small changes in chemical shift are observed for 
Hf which we believe reflects a balance between the expected downfield shift due to 
conformational change and upfield shift due to the shielding effect of the aromatic 
ring of the guest. Interestingly, we found no evidence by 1H NMR of binding of 1 or 
2 (at mM concentrations) toward Asp and Glu which contain CO2H groups in their 
side chains that are expected to be present in their anionic CO2ˉ form at pD 7.4. This 
result is in accord with previous observations from CB[n] molecular recognition that 
the electrostatically negative ureidyl C = O portals do not tolerate the presence of 
guest negative charge at the portals.59, 132 Furthermore, the presence of the SO3ˉ 
solubilizing groups on 1 and 2 would be expected to electrostatically destabilize 
complexes with Asp and Glu. Finally, for H-Gly-NH2, H-Ala-NH2, and H-Ser-NH2 
which have no, small, or hydrophilic side chains we observe only small changes (e.g. 
Δδ and broadening) in the 1H NMR which probably indicates very weak binding or 
non-inclusion binding (e.g. portal binding) or a combination thereof.  In the 1H NMR 
experiments, we often observed substantial upfield shifts for guest resonances at 1:1 
host:guest stoichiometry which moved back toward the position for complexed guest 
at 1:2 host:guest ratios which suggested the formation of 1:1 complexes. We 
constructed Job plots133 to further established the 1:1 host:guest stoichiometry in 
select cases where the resonances were sharp enough to be easily monitored. For 
example, Figure II-5 shows a Job plot constructed for mixtures of 1 and H-Lys-NH2 
at a constant total concentration of 1 mM in phosphate buffered D2O (pD 7.40). The 




displays a maximum at a mole fraction of 0.5 which firmly establishes the 1:1 
absolute stoichiometry of the 1•H-Lys- NH2 complex. A related Job plot was 
constructed to confirm the 1:1 stoichiometry of the 1•H-Arg-NH2 complex. 
 
Figure II-5. Job plot constructed for the interaction of 1 with H-Lys-NH2 ([1] + [H-
Lys-NH2] = 1 mM) monitoring the chemical shift of Hf on 1 by 1H NMR 
spectroscopy (600 MHz, RT, 20 mM NaH2PO4 buffered D2O, pD 7.40). The solid 
line serves as a guide for the eye. 
2.4 Isothermal titration calorimetry (ITC) determination of host•guest energetics 
The substantial broadening and intermediate exchange kinetics observed in 
the 1H NMR spectra of the complexes of 1 and 2 with amino acid amide guests 
complicates the use of NMR to determine binding constants. Accordingly, we turned 
to ITC to determine the thermodynamic parameters for binding. Figure II-6(a) shows 
a representative ITC Thermogram recorded for the titration of 1 (100 μM) in the ITC 
cell with a solution of H-Phe-NH2 (1 mM) in the ITC syringe and the fitting of the 
data to a 1:1 binding model using the PEAQ ITC analysis software (Figure II-6(b)). 




1 for the 1•H-Phe-NH2 complex. Analogous ITC titrations were performed for the 
complexation between hosts 1 and 2 and the remainder of the amino acid amides, 
amino acids, and N-acetyl amino acid amides (Appendix 1), and the results are 
presented in Table 1. 
 
Figure II-6. (a) Thermogram obtained during the titration of 1 (100 μM) in the cell 
with H-Phe-NH2 (1 mM) in the syringe (298.0 K, 20 mM sodium phosphate buffered 
H2O, pH 7.4) and (b) fitting of the data to a 1:1 binding model with Kₐ = 2.62 x 106 
M-1 and ΔH = −17.1 kcal mol-1. 
2.4.1 Discussion of trends in the thermodynamic parameters 
The dynamic range of binding constants presented in Table 1 spans the range 
from102 M-1 to above 106 M-1. Given the constraints of this relatively narrow range, 




present them here grouped according to the chemical nature of the amino acid amide 
side chain (e.g. anionic, cationic, aromatic, hydrophobic aliphatic, polar).  
 
Table II-1. Thermodynamic parameters obtained by ITC for the interaction of 1 and 
2 with the amino acid amides, N-acetyl amino amides, and amino acids. 
 Host 1 Host 2 


















-8.76 -17.1 ± 
0.04 
8.36 3.24 × 
106 








-6.68 -12.5 ± 
0.153 
5.83 9.61 × 
104 








-4.94 -8.95 ± 
0.448 
4.01 2.99 × 
104 
-6.11 -10.1 ± 
0.239 
4.04 






-7.38 -14.8 ± 
0.064 
7.43 3.98 × 
106 








-5.50 -7.41 ± 
0.132 
1.91 1.14 × 
105 







-3.99 -10.4 ± 
0.854 
6.43 3.56 × 
104 
-6.21 -5.38 ± 
0.30 
-0.828 






-8.19 -15.1 ± 
0.03 
6.89 9.52 × 
105 








-5.46 -8.60 ± 
0.226 
3.14 2.03 × 
104 







-4.23 -9.36 ± 
0.371 
5.12 3.06 × 
103 
-4.76 -8.21 ± 
0.079 
3.45 





-5.97 -9.72 ± 
0.128 
3.75 2.61 × 
104 









-8.01 -10.9 ± 
0.02 
2.90 1.41 × 
105 








-3.44 -11.6 ± 
5.02 











-5.45 -7.13 ± 
0.220 
1.68 8.06 × 
103 
-5.33 -2.84 ± 
0.078 
-2.49 






-7.98 -11.6 ± 
0.02 
3.57 8.26 × 
104 








-4.34 -3.93 ± 
0.099 
-0.416 2.39 × 
103 







-5.34 -6.84 ± 
0.178 
1.50 7.87 × 
103 
-5.32 -5.44 ± 
0.248 
0.119 






-5.69 -5.71 ± 
0.213 
0.02 7.25 × 
103 







-5.59 -0.867 ± 
0.007 










-5.35 -0.546 ± 
0.112 






-4.31 1.42 ± 
1.22 
-5.73 1.35 × 
103 








-6.99 -13.1 ± 
0.04 
6.08 8.85 × 
104 
-6.75 -11.7 ± 
0.04 
4.97 





-6.79 -10.8 ± 
0.04 
4.02 1.68 × 
105 








-5.66 -10.1 ± 
0.085 
4.40 2.15 × 
104 








-7.44 -9.80 ± 
0.027 
2.35 2.29 × 
105 







-5.13 -5.43 ± 
0.149 
0.299 1.70 × 
104 






408 -3.56 -5.32 ± 
0.545 






80.6 -2.60 -3.88 ± 
0.742 




Firstly, in agreement with our 1H NMR measurements, no heat is evolved 
during the titration of 1 or 2 with the H-Asp-NH2 and H-Glu-NH2 and we therefore 
conclude that no binding occurs with these amino acid amides that contain anionic 




cavity for hydrophobic and neutral binding epitopes over hydrophilic and anionic 
groups.58, 132 Second, we find that the aromatic amino acid amides (H-Phe-NH2, H-
Trp-NH2, H-Tyr-NH2 form the tightest complexes with 1 and 2 with Ka values that 
exceed 106 M-1 and with large enthalpic driving forces in the range of −15 – −18 kcal 
mol-1. This trend is not so surprising in light of the hydrophobicity of the aromatic 
rings of the amino acid amides, the ability of aromatic walls of 1 and 2 to engage in 
π-π interactions with the guest, and of course the precedent from the work of Kim, 
Inoue, Nau and Urbach that showed that peptides with aromatic side chains at the N-
terminus are bound selectively by CB[7].4, 67, 88, 130 Macrocyclic CB[7] has been 
reported to bind Phe-Gly-Gly (Ka = 2.8 x 106 M-1), Phe-Gly (Ka = 3 x 107 M-1), Tyr-
Gly (Ka = 3.6 x 106 M-1), and Trp-Gly (Ka = 5.6 x 105 M-1) with affinities that are 
comparable to those observed for 1 and 2.4, 88 For H-Phe-NH2 and H-Trp-NH2, the 
larger host 2 binds stronger than 1 as expected based on its larger cavity size.62, 102 H-
His-NH2 with its hydrophilic and charged aromatic side chain is bound significantly 
weaker to both 1 and 2 (Ka ≈ 104 M-1) and with significantly lower enthalpic driving 
force. Third, H-Lys-NH2 and H-Arg-NH2 which are dicationic at neutral pH and 
contain 4–5 C-atoms between cationic N-atoms bind toward 1 with affinities (Ka ≈ 7 
× 105 M-1) that are only slightly lower that the aromatic amino acid amides. They do 
not reach the very high affinity typically observed for diammonium ion complexes 
with cucurbiturils presumably because of the presence of the CONH2 group. Host 1 
displays higher affinity than 2 toward H-Lys-NH2 (5.3-fold) and H-Arg-NH2 (8.6-
fold) because the cavity of 1 is smaller than 2 and prefers narrower (e.g. alkylene) 




chains, we find that H-Met-NH2 binds most strongly to 1 (Ka = 1.32 x 105 M-1) and 2 
(Ka = 8.85 x 104 M-1) with substantial enthalpic driving forces. This is not surprising 
given that methionine has both the largest side chain surface area and the least 
favorable free energy of transfer from cyclohexane to water which enhances the 
hydrophobic driving force for complexation.4 The remaining polar amino acid amides 
(H-Gln-NH2, H-Asn-NH2, H-Thr-NH2, H-Ser-NH2) bind more weakly with Ka in the 
102 –104 M-1 range which reflects the need to desolvate the side chains polar OH and 
CONH2 functional groups as they enter the host cavity. As expected, a comparison of 
the binding constant of 1 toward H-Gln-NH2 versus H-Asn-NH2 and H-Thr-NH2 
versus H-Ser-NH2 reveals that the compound with the additional CH2-group in the 
side chain is the stronger binder.58 Finally, the amino acid amides with hydrophobic 
aliphatic side chains (H-Ile-NH2, H-Val-NH2, H-Leu-NH2, H-Pro-NH2) bind to 1 and 
2 with Ka values in the 6 × 103 to 3 × 105 M-1 range and ΔH values in the−5 to−7.5 
kcalmol-1 range with; host 2 is generally the tighter binder. The order of binding 
affinity toward 1 and 2 follows the order H-Pro-NH2<H-Val-NH2 < H-Ile-NH2 < H-
Leu-NH2. As expected, H-Pro-NH2 and H-Val-NH2 which have fewer C-atoms in the 
side chain relative to H-Ile-NH2 and H-Leu-NH2 (e.g. 3 versus 4) bind more weakly. 
We speculate that the pyrrolidine ring of H-Pro-NH2 displays reduced affinity 
because the preferences of ion–dipole and hydrophobic effect cannot be fully satisfied 
simultaneously. Finally, H-Gly-NH2 and H-Ala-NH2 with no or minimal side chains 





2.4.2 Influence of N-acetylation and C-amidation 
We measured the binding of 1 and 2 toward the unmodified amino acid and 
N-acetyl amino acid forms of phenylalanine, tryptophan, tyrosine, lysine, and 
arginine (Table II-1). We hypothesized that the amino acid amides would bind more 
strongly than the amino acids themselves due to the absence of unfavorable CO2- to 
SO3- and/or C=O portal interactions. Similarly, we expected that the amino acid 
amides would bind more strongly than the N-acetyl amino acid amides due to the loss 
of NH3+ to O=C ion–dipole in the later. These interactions are presented 
schematically in Figure II-7. For 1•H-Phe-NH2 (2•H-Phe-NH2) the loss of 
NH3+•••O=C ion–dipole interactions costs 3.8 kcal mol-1 (2.8 kcal mol-1) whereas the 
introduction of unfavorable CO2ˉ electrostatic interactions costs 2.1 kcal mol-1 (2.1 
kcal mol-1). Related losses of free energy were observed for the complexes of 1 (2) 
toward H-Trp-NH2 (1: 3.4 and 1.9 kcal mol-1 ; 2: 2.8 and 2.1 kcal mol-1) and H-Tyr-
NH2 (1: 3.96 and 2.7 kcal mol-1; 2: 3.4 and 2.3 kcal mol-1) upon acylation of the N-
terminus and introduction of a C-terminal CO2ˉ group. In contrast, for the dicationic 
amino acids H-Lys-NH2 (1: 2.6 and 4.6 kcal mol-1 ; 2: 1.7 and 3.4 kcal mol-1) and H-
Arg-NH2 (1: 2.6 and 3.6 kcal mol-1; 2: 1.4 and 2.1 kcal mol-1) the introduction of the 
CO2ˉ group is energetically more costly than removal of the NH3+•••O=C ion–dipole 
interactions. We rationalize this observation based on the fact that for Lys and Arg 
the diammonium spans the two C=O portals which conformationally fixes the CO2ˉ 
group within the cavity near the electrostatically negative C=O portals of 1 or 2. 
Accordingly, we conclude that ion–dipole interactions play a primary role in 


































































Figure II-7. (Colour online) Schematic illustration of the complexes of 1 with H-Phe-
CO2ˉ, H-Phe-NH2, and Ac-Phe-NH2 along with their driving forces and relative 
stabilities. 
 
2.5 Influence of neighboring residues  
We were inspired by the recent work of Urbach which showed that CB[8] is 
capable of simultaneously binding two adjacent side chains within the context of a 
tripeptide with nanomolar affinity.65 Accordingly, we sought to determine if acyclic 
cucurbiturils like 1 or 2 could recognize an N-terminal Phe along with an adjacent 
residues sidechain. We selected FGA as control tripeptide along with six tripeptides 
(FFA, FLA, FVA, FIA, FPA, FKA) with adjacent aromatic, hydrophobic, or cationic 
sidechain. ITC experiments were performed for these tripeptides toward 1 and 2 and 
the results are given in Table II-2. First, we found that the 1•FGA complex (Ka = 1.48 
× 106 M-1 ; ΔH = −13.3 kcal mol-1) is of comparable affinity and enthalpic driving 
force to the 1•H-Phe-NH2 complex (Ka = 2.62 × 106 M-1; ΔH = −17.1 kcal mol-1). 
Interestingly, compared to the 1•FGA complex all of the tripeptides with aromatic, 




complex is the weakest with Ka = 6.62 x 104 M-1 presumably due to the loss of a 
potential N-H•••O=C H-bond due to the tertiary amide bond at proline. All these 
results suggest that the cavity of 1 cannot expand to accommodate a second residue 
and that the second residue experiences unfavourable steric interactions which 
reduces affinity. The binding of 1 to FVA was of relevance to our planned binding 
experiments toward insulin since the N-terminus of insulin also has the FV sequence. 
Unfortunately, the 1•FVA complex has similar affinity to all the other tripeptides 
tested. The behavior of 2 is more subtle and the affinity toward all the tripeptides 
cluster around 105M-1. Despite the previously demonstrated ability of 1 and 2 to 
expand its cavity to accommodate larger guests with roughly circular cross sections in 
the form of adamantanes, steroids, and even carbon nanotubes62, 93, they prefer to bind 
a single narrower alkyl and phenyl ring when given the option.102, 114, 134 
 
Table II-2. Thermodynamic parameters obtained by ITC for the interaction of 1 and 
2 with tripeptides. 
 Host 1 Host 2 















FGA 1.48 x 106 -8.42 -13.3 ± 0.038 4.93 1.20 x 105 -6.93 -18.1 ±0.697 11.1 
FFA 2.52 x 105 -7.37 -13.7 ±0.097 6.37 1.22 x 105 -6.94 -12.5 ± 0.27 5.56 
FLA 1.57 x 105 -7.09 -13.4 ±0.201 6.27 2.59 x 105 -7.39 -10.1 ±0.176 2.72 
FIA 1.40 x 105 -7.02 -13.3 ± 0.121 6.32 2.62 x105 -7.39 -10.0 ±0.131 2.62 
FVA 3.89 x 105 -7.63 -12.7 ± 0.076 5.07 3.84 x 105 -7.62 -11.7 ± 0.03 4.13 
FPA 6.62 x 104 -6.58 -12.4 ±0.169 5.81 1.06 x 105 -6.86 -8.16 ±0.207 1.30 





2.6 Molecular recognition of insulin by 1, 2, and CB[7] 
Finally, we decided to study the interaction of 1 and 2 with a protein. As the 
model protein, we selected insulin based on the pioneering work of the Urbach 
group.63 Accordingly, we sought to measure the binding affinity of 1 and 2 toward 
insulin and compare the results to those measured previously with CB[7]. ITC 
binding studies were performed in our standard 20 mM sodium phosphate buffered 
water at pH 7.4 containing 4 mM EDTA which sequesters metal ions that promote 
oligomerization of insulin. Table II-3 shows the results of the ITC studies which 
indicates that CB[7] binds insulin the strongest followed closely by 2 and then 1. The 
affinity of the insulin•CB[7] complex (5.59 x 105 M-1) is slightly lower than that 
measured previously by Urbach (Ka = 1.5 x 106 M-1) which we attribute to the less 
competitive 10mM sodium phosphate buffer they used.63 Satisfyingly, the binding 
constants measured for 1 and 2 toward insulin are comparable to those measured 
toward the FVA peptide which indicates that secondary electrostatic interactions 
between the tetra-anionic hosts and insulin are not energetically costly. In 
comparison, the Ka values measured for the interaction of H-Phe-NH2 with 1 and 2 
are about 10-fold higher (Table II-1) which confirms the sensitivity of 1 and 2 to the 
steric bulk at the neighboring amino acid residue. 
 
Table II-3. Thermodynamic parameters obtained by ITC for the interaction of CB 
[7], 1, and 2 with Insulin. 
HOST Ka / M-1 ΔG ΔH -TΔS 
CB[7] 5.59 x 105 -7.84 -8.97 ± 0.232 1.13 
1 1.32 x 105 -6.99 -16.9 ± 0.225 9.91 






In summary, we have delineated the binding properties of acyclic CB[n]-type 
receptors 1 and 2 toward 19 amino acid amides by a combination of 1H NMR 
spectroscopy and ITC. The side chains typically undergo cavity inclusion whereas the 
N-terminus binds at the C=O portal by ion–dipole and ion-SO3ˉ interactions. Binding 
constants range from <102 (for anionic and small side chains) to ≈ 106 M-1 for amino 
acid amides with aromatic (Phe, Trp, Tyr) and even cationic (Lys and Arg) side 
chains. The broader range of residues undergoing high-affinity binding by 1 and 2 
stands in contrast to that of CB[7] which suggests a broad range of potential 
applications. Studies of the binding of 1 and 2 toward the N-acetyl amino acid amides 
and the free amino acids allowed us to quantify the energetic contributions of 
electrostatics to the binding process. For example, the removal of the NH3+•••O=C 
ion–dipole interactions (e.g. 1•H-Phe-NH2 versus 1•Ac-Phe-NH2) costs 3.8 kcal mol-1 
whereas the introduction of unfavorable CO2- electrostatic interactions costs 2.1 kcal 
mol-1. Given the propensity of acyclic CB[n] to expand their cavity to bind to large 
guests, we explored the possibility of 1 or 2 simultaneously binding two amino acid 
side chains but observed no evidence for such phenomena. Finally, we demonstrate 
that 1 and 2 bind to insulin with affinities similar to CB[7]. Overall, the work 
demonstrates that acyclic CB[n] have a broad affinity toward aromatic and cationic 
side chains of N-terminal amino acids which suggests that acyclic CB[n] have a 





Chapter 3: Triptycene Walled Glycoluril Trimer: Synthesis and 
Recognition Properties 
 
The work presented in this chapter was take from Zebaze Ndendjio, S.; Liu, W.; 
Yvanez, N.; Meng, Z.; Zavalij, P.Y.; Isaacs, L. Triptycene walled glycoluril trimer: 
synthesis and recognition properties. New J. Chem. 2019. In this work, Liu first 
developed a synthetic procedure to synthesize impure trimer triptycene glycoluril 
host. Yvanez then attempted the purification of the trimer host by HPLC but with 
limited results. After Yvanez departure, I succeeded in the purification of the trimer 
host by a recrystallization method. After obtaining the pure host I was able to conduct 
the NMR and ITC studies, most importantly I was fortunate enough to obtain a 
crystal structure of the trimer triptycene host. 
3.1 Introduction 
The synthesis and molecular recognition properties of the cucurbit[n]uril 
(CB[n]) family of molecular container compounds has undergone rapid development 
since the turn of the millennium49 Figure III-1 shows the molecular structure of CB[n] 
which are composed of n glycoluril units connected by 2n methylene bridges that 
form a barrel shaped macrocycle with two electrostatically negative ureidyl carbonyl 
fringed portals and a central hydrophobic cavity. Accordingly, macrocyclic CB[n] 
bind tightly to hydrophobic (di)ammonium ions in water with binding constants 





Figure III-1. Structure of CB[n] (n = 5, 6, 7, 8, 10, 14), acyclic CB[n]-type receptor 
M1, and DimerTrip. 
 
The very high affinity of CB[n]•guest complex has been traced, in part to the 
presence of intracavity waters that lack a full complement of H-bonds that are 
released upon complexation.79 Accordingly, the Ka values for CB[n]• guest complexes 
have been featured prominently in a series of blinded challenges (SAMPL and 
Hydrophobe) that aim to improve computational approaches to free energy 
calculations in water. CB[n]•guest complexes respond sensitively to appropriate 
stimuli (e.g. pH, chemical, electrochemical, photochemical)116 allowing them to be 
used as a high-fidelity switching element in complex systems. Accordingly, 














































































component of (bio)sensing ensembles,119 for drug formulation, delivery and 
sequestration,136  to create supramolecular organic frameworks,137 and to perform 
supramolecular catalysis.48, 54 With the development of functionalized CB[n], the 
range of application has been expanded to include CB[n] based targeted drug delivery 
and theranostics, materials for protein capture, supramolecular Velcro, and 
nanoparticle based optical assays.138 
In recent years, we and others have been studying acyclic CB[n]-type 
receptors that feature a central glycoluril oligomer (e.g. dimer–tetramer) that is 
capped by aromatic sidewalls.95, 139-143  Figure III-1 shows the structure of the 
prototypical acyclic CB[n] (M1) which features a central glycoluril tetramer, o-
xylylene sidewalls, and sulfonate solubilizing groups. M1 shows excellent 
biocompatibility according to a variety of in vitro and in vivo assays97, 144 and is 
therefore considered for real world applications. For example, M1 and analogues 
have been used as solubilizing excipients for insoluble drugs,102 for pH triggered 
delivery agents,145 as in vivo sequestration agents for neuromuscular blockers and 
drugs of abuse,62 and as components of sensing arrays.107 Most recently, we have 
created chimeric receptors comprising glycoluril monomer, dimer, or tetramer units 
with triptycene sidewalls with the goal of increasing binding capacity and binding 
strength and observed interesting behavior like triggered decomposition of vesicles 
and the ability to wrap around macrocyclic guests.146 In this paper we prepare acyclic 
CB[n]-type host 1 derived from glycoluril trimer, investigate its binding properties 




as a blinded dataset for the SAMPL7 challenge,147 and finally to assess its potential as 
a sequestration agent toward drugs of abuse. 
3.2 Results and discussion 
This results and discussion section is organized as follows. First, we present 
the design, synthesis, and characterization of host 1. Next, we quantify the self-
association propensity of 1 and perform qualitative 1H NMR based host•guest 
complexation studies. Subsequently, we measure the complexation thermodynamic 
parameters by isothermal titration calorimetry (ITC) and discuss the observed 
structure binding constant trends 
3.2.1 Design, synthesis, and characterization of host 1 
The synthesis of host 1 is based on our previously described building block 
approach95 involving the electrophilic aromatic substitution reactions between 
glycoluril bis(cyclic ethers) and activated aromatic rings. Accordingly, we reacted 
glycoluril trimer 2114 with triptycene derivative 3108 under acidic conditions 
(TFA, Ac2O) which delivered crude 1 after precipitation with EtOH. Purification of 1 
was challenging and required a combination of washing with EtOH and acetone 
followed by recrystallization from mixtures of EtOH and H2O to deliver 1 in 4.4% 
isolated yield. The chemical structure of 1 was fully elucidated by spectroscopic 
means and was further confirmed by single crystal X-ray diffraction studies (vide 
infra). The 1H NMR spectrum of 1 in D2O shows a single resonance for the glycoluril 
methine protons (Hj), two pairs of resonances for the diastereotopic methylene 




(Ha,b and Hc,d). The number of resonances is fully consistent with the time-averaged 
C2v-symmetry depicted in Scheme III-1. However, the resonance for Hb on the tip of 
the aromatic ring is upfield shifts and appears at 5.7 ppm which suggests that 
uncomplexed 1 assumes a self-folded conformation in water (vide infra) similar to 
previously prepared triptycene walled glycoluril tetramer.108 The 13C NMR spectrum 
for 1 recorded in DMSO-d6 displays 22 resonances which is also in agreement with 
time averaged C2v-symmetry. Finally, the high resolution ESI-MS spectrum of 1 
shows a doubly charged ion at m/z 829.20204 which is in accord with the calculated 

















































R = CH2CH2CH2SO3Nam n o
 
Scheme III-1. Synthesis of host 1. 
3.2.2 Self-association properties of host 1 
Before proceeding to investigate the host•guest properties of 1 we perform 




measured the 1H NMR spectra of a series of solutions of 1 in D2O from its solubility 
limit of 3 mM down to 0.05 mM (Appendix 2,Figure S4, ESI†). We observe small 
changes in chemical shift of many protons including Hb, Hk/l, and Hf. Figure III-2 
shows a plot of the concentration of 1 versus chemical shift of Hb that was fitted to a 
dimerization model in ScientistTM (ESI†) which allowed us to extract the self-
association constant (Ks = 480 ± 81 M-1). The measurement of the thermodynamic 
parameters of complexation of 1 (vide infra) were measured by ITC at [1] = 100 mM 
where the host remains monomeric. 
 
Figure III-2.  Plot of chemical shift of Hb versus [1] used to determine the self-
association constant Ks = 480 ± 81 M-1 for 1. 
3.2.3 X-ray crystal structure of 1 
We were fortunate to obtain single crystals of 1 by recrystallization from 
mixtures of EtOH and H2O and to solve its structure by X-ray crystallography 
(CCDC-1949769). † Figure III-3a and b show stereoscopic representations of the two 
independent molecules of 1 in the crystal. The molecule of 1 in Figure III-3a is C2-
symmetric and features an out-of-plane helical distortion that renders it chiral. 




chiral; it also includes a solvating CF3CO2H molecule. Interestingly, only one sense 
of handedness is present in the crystal structure of 1 and therefore the crystal is a 
conglomerate. Figure III-3c shows a stereoview of how these two different molecules 
of 1 pack next to each other in the crystal. The external face of the triptycene unit of 
one molecule of 1 embraces the convex face of the glycoluril region of the adjacent 
molecule of 1 and vice versa. The fact that two different conformations were 
observed in the crystal and the 1H NMR evidence of a p-stacked conformation 
presented above highlights the conformational flexibility of the acyclic CB[n] that 
enables it to bind to a wide variety of guests.100  
 
Figure III-3. Cross-eyed stereoviews of the crystal structure of 1. (a and b) Two 
independent molecules of 1. (c) Packing of the two independent molecules of 1 into a 
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Figure III-4. Structures of guests 4–26 used in this study 
 
Next, we decided to perform a qualitative investigation of host•guest binding 
of 1 toward guests 4–19 (Figure III-4) by 1H NMR spectroscopy (ESI†). For example, 
Figure III-5a–c shows the 1H NMR spectra recorded for uncomplexed 8, and 1: 1 and 
1 : 2 mixtures of 1 with 8. As expected, the resonances for guest protons Hr, Hs, and 
Ht undergo substantial upfield shifts (41.5 ppm) upon formation of the 1•8 complex 
reflecting the encapsulation of the hydrophobic octylene chain inside the hydrophobic 
cavity of the host defined by the four aromatic rings of the triptycene sidewalls. The 




twisting of 1 in the complex which deepens the cavity and brings Hq into proximity of 
a triptycene sidewall. The presence of separate resonances for free guest 8 and bound 
guest 8 (Figure III- 5b) at a 1: 2 (1: 8) stoichiometry reflects the slow kinetics of 
host•guest exchange on the chemical shift timescale. Host 1 also undergoes 
significant changes in chemical shift upon formation of the 1•8 complex. For 
example, the triptycene bridgehead methine resonance (He) moves downfield by 0.3 
ppm. Most significantly, however, the resonance for Hb undergoes a substantial 
downfield shift (E1.78 ppm) upon complexation which indicates that guest binding 
unfolds the self-folded conformation described above. Similar qualitative binding 
studies were performed for the remainder of the guests. In accord with expectations, 
we find that the resonances for the hydrophobic regions of guests 4–19 undergo 
substantial upfield shifts upon complexation due to the shielding effect of the 
triptycene sidewalls. The complexes of 1 with guests 5–10, 12, 13, 16, 17, and 18 
display slow to intermediate exchange kinetics (e.g. two sets of broadened 
resonances) on the NMR timescale whereas guests 4, 11, 14–15, and 19–26 display 






Figure III-5. 1H NMR spectra recorded (600 MHz, RT, 20 mM sodium phosphate 
buffered D2O, pH 7.0) for: (a) guest 8 (2 mM), (b) a mixture of 1 (250 mM) and 8 
(500 mM), (c) a mixture of 1 (250 mM) and 8 (250 mM), and (d) host 1 (250 mM). 
 
3.3 Measurement and discussion of the thermodynamic parameters of complex 
formation 
After qualitatively assessing the host•guest binding properties of 1 we decided 
to quantify the binding constants (Ka, M-1). Given that CB[n]•guest binding constants 
typically exceed the dynamic range of 1H NMR we decided to use ITC to 
simultaneously measure Ka and DH; ITC experiments were conducted in duplicate. 
For example, Figure III-6a shows the thermogram recorded when a solution of 1 (100 




the syringe. Figure III-6b shows the fitting of the integrated heat values to a 1: 1 
binding model with Ka = 1.33 106 M-1 and ∆H = 8.58 kcal mol-1. For the 1•guest 
values with Ka ≤ 4.08 ×106 M-1 reported in Table III-1 we performed similar direct 
ITC titrations. For complexes with higher Ka values, and therefore c-values that 
exceed the recommended range,148 we turned to competitive ITC titrations. In 
competition ITC, a solution of the host and an excess of a weaker binding guest is 
titrated with a solution of the tighter binding guest. Using the known concentrations 
of host, weak guest, and host•weak guest Ka and ∆H as inputs allowed us to fit the 
thermogram to a competitive binding model in the PEAQ-ITC data analysis software 
to extract the thermodynamic constants for the tighter host•guest complexes reported 





Figure III-6. (a) ITC thermogram recorded during the titration of host 1 (100 mM) in 
the cell with guest 5 (1.0 mM) in the syringe, (b) fitting of the data to a 1: 1 binding 
model with Ka = 1.33×106 M-1. 
 
3.3.1 Magnitude of binding constants and enthalpies 
A perusal of Table III-1 reveals that the Ka values for 1 with guests 4–19 fall 
in the range of 4670 – 4.55×108 M-1; this large dynamic range of Ka values is 
desirable given their use as the blinded dataset in the upcoming SAMPL7 challenge. 
The complexes are all driven by favorable enthalpic contributions with ∆H values 
ranging from 3.98 to 14.7 kcal mol-1. The substantial enthalpic driving forces 
observed are not unexpected given that cavity bound waters that lack a full 
complement of H-bonds are known to provide an enthalpic driving force for the 
complexes of macrocyclic CB[n].57 
 
Table III-1. Binding constants (Ka, M-1) and binding enthalpies (∆H, kcal mol-1) 
measured for 1•guest. Binding constants (Ka, M-1) measured for DimerTrip•guest, 
and M1•guest complexes (298 K, 20 mM NaH2PO4 buffered water, pH 7.4) 
 
G 1 DimerTrip / M1 f 
4 (2.92 ± 0.257) × 104a 
-6.03 ± 0.260 
(4.47 ± 0.75) × 103 
– 
5 (1.33 ± 0.0308) × 106 a 
-8.58 ± 0.021 
(1.23 ± 0.05) × 105 
– 
6 (2.29 ± 0.166) × 107c 
-10.8 ± 0.044 
(8.81 ± 0.59) × 105 
(5.05 ± 0.31) × 107 
6DQ (5.00 ± 0.209) × 107c 
-12.7 ± 0.028 
(1.26 ± 0.09) × 106 
(8.93 ± 0.33) × 107 
6Q (1.20 ± 0.0329) × 106 a 
-8.54 ± 0.027 
(3.41 ± 0.5) × 104 
(1.24 ± 0.06) × 106 




-10.1 ± 0.036 – 
8 (1.41 ± 0.195) × 108d 
-11.5 ± 0.094 
(6.27 ± 0.41) × 105 
– 
9 (2.42 ± 0.334) × 108d 
-11.4 ± 0.062 
(5.23 ± 0.34) × 105 
– 
10 (2.81 ± 0.507) × 108e 
-11.3 ± 0.068 
(3.7 ± 0.16) × 105 
– 
12 (4.55 ± 0.943) × 108d 
-10.4 ± 0.064 
– 
– 
11 (3.57 ± 0.139) × 105a 
-4.83 ± 0.036 
– 
(1.73 ± 0.20) × 107 
13 (1.13 ± 0.109) × 107a 
-10.1 ± 0.119 
(1.04 ± 0.16) × 104 
(1.70 ± 0.05) × 107 
14 (4.08 ± 0.341) × 106a 
-7.41 ± 0.084 
– 
– 
15 (1.11 ± 0.0743) × 106 a 
-5.88 ± 0.049 
– 
– 
16 (8.77 ± 0.493) × 106c 
-10.5 ± 0.044 
(7.1 ± 0.23) × 104 
(1.67 ± 0.08) × 108 
17 (5.81 ± 0.443) × 107c 
-12.4 ± 0.045 
– 
(4.69 ± 0.22) × 108 
18 (3.57 ± 0.185) × 108d 
-13.7 ± 0.039 
– 
– 
19 (5.95 ± 0.222) × 104a 
-6.61 ± 0.088 
(3.29 ± 0.71) × 103 
(1.95 ± 0.09) × 106 
20 (1.33 ± 0.0414) × 107 c 
-14.7 ± 0.036 
– 
(1.1± 0.04) × 107 
21 (9.80 ± 0.317) × 104a 
-5.09 ± 0.042 
– 
(4.7 ± 0.5) × 104 
22 (5.61 ± 0.583) × 104b 
-3.98 ± 0.0942 
– 
– 
23 (8.47 ± 3.10) × 103 a 
-4.95 ± 2.30 
– 
(1.1 ± 0.1) × 104 
24 (9.43 ± 0.198) × 105a 
-9.63 ± 0.025 
– 
(7.5 ± 2.9) × 106 
25 (3.70 ± 0.111) × 104a 
-9.99 ± 0.129 
– 
(6.6 ± 0.4) × 105 
26 (4.67 ± 0.446) × 103b 
-8.92 ± 0.445 
– 
1.8 × 105 
 
3.3.2 Influence of diammonium ion length 
CB[6] is known to preferentially bind to diammonium ions whose length (e.g. 
H3N+•••NH3+) matches the C=O•••O=C distances of the host; CB[6]•5 and CB[6]•6 
display maximal affinity.58 An examination of Table 1 reveals a very different trend 
in Ka with the Ka values for increasing steadily from 1•4 (2.92 × 104 M-1) to 1•8 (1.41 




Host 1 can accommodate longer diamines because it can flex and expand its cavity 
and because the (CH2)3SO3ˉ arms deepen the cavity while providing for new 
ammonium•••sulfonate interactions. Similar observations have been made previously 
for a carboxylate analogue of M1.94   
3.3.3 Drugs of abuse 
Recently, we have found that acyclic CB[n]-type receptors (e.g. M1) bind 
tightly to neuromuscular blocking agents and function as in vivo reversal agents.62, 97, 
144 More recently, we found that acyclic CB[n] bind strongly to methamphetamine 
and fentanyl and modulate the hyperlocomotion induced by methamphetamine in 
vivo (rats).98 Accordingly, we decided to determine the binding affinities of 1 toward 
a panel of drugs of abuse (20 –26) by ITC (Table III-1). Most notable is the 
interaction between 1 and fentanyl with Kd = 75 nM which makes it suitable as a 
potential in vivo reversal agent. The interactions between 1 and 21–26 are 
substantially weaker (Ka < 106 M-1). The data in Table III-1 also allow a comparison 
between 1 and M1. As can be seen, M1 is often a slightly stronger host than 1, most 
notably toward methamphetamine. This trend is not unexpected given that acyclic 
CB[n] based on glycoluril tetramer have more fully formed ureidyl C=O portals and 
larger cavities114.  
3.3.4 Influence of guest charge 
Compounds 6DQ and 6Q differ in the number of quaternary ammonium ions 
while maintaining a common hexylene hydrophobic core. Table 1 shows that the 




stronger than 1•6Q (Ka = 1.20 × 106 M-1). Similar, but more pronounced trends are 
seen for CB[n]•guest complexes where an additional ion–dipole interaction 
commonly increases Ka by 102 –103 M-1.149, 150 
 3.3.5 Influence of the cationic headgroup 
Compounds 6 and 6DQ as well as 11 and 13 differ only in the presence of 
primary ammonium (NH3+) or quaternary ammonium (NMe3+) ion centers. Table III-
1 shows that 1 binds the quaternary guests (6DQ and 13) more tightly by 2.2-fold and 
31.7-fold. Related effects have been seen for macrocyclic CB[7] complexes where the 
magnitude of the effect is dependent on the nature of the hydrophobic moiety.59, 60, 151 
3.3.6 Influence of guest hydrophobic residue 
Macrocyclic CB[n]•guest complexes are very sensitive to the size and shape 
of the guest because the cavity of these hosts cannot easily expand its size to alleviate 
steric interactions.58, 59 For example, CB[7] binds 11 (Ka = 4.23 × 1012 M-1) more that 
108-fold stronger than 3,5-dimethyladamantaneamine (memantine, Ka = 25000 M-1).59 
Consider the following series of guests: 6, 16, 17, 18, and 15. Across this series, there 
is a constant number of C-atoms (6) in between the two ammonium ions centers. 
However, the total number of C-atoms in the hydrophobic moiety of the guest (6: 6; 
16: 8, 17: 10, 18: 10, and 15: 14) and the nature of hydrophobicity of the moiety (e.g. 
aromatic 16 and 17 versus aliphatic 6, 18, 15) is different. As the number of C-atoms 
of the guest is increased one would expect larger Ka values due to more favorable 
desolvation of the larger guests upon complexation. Conversely, as the size and cross-




might expect decreased Ka values due to energetically costly expansion of the host 
cavity. Within this series of guests, we observe a maximum Ka value of (3.57 ± 
0.185) × 108 M-1 for 1•18. As expected, the bulky multicyclic guests 21, 22, and 26 
are quite poor guests for 1 with Ka in the 104–105 M-1 range. 
3.3.7 Comparisons between hosts 
Table III-1 also presents the binding constants of two related hosts (M1 and 
DimerTrip) drawn from the literature.98, 146, 152 Dimer-Trip is an analogue of 1 that 
only contains two glycoluril rings. Accordingly, the cavity of Dimer Trip is CB[6] 
sized and therefore smaller than the cavity of 1. A comparison of the binding 
constants given in Table 1 reveals that 1 is a superior host compared to Dimer Trip by 
6.5 to 1086-fold. The highest selectivities are seen for bulky guests (13: 1086-fold; 
10: 760-fold) which cannot be fully encapsulated inside Dimer Trip without 
substantial energetic penalties for cavity expansion. M1 differs from 1 by the number 
of glycolurils (4 versus 3) unit and by the different sidewalls (benzene versus 
triptycene). A comparison of the Ka values in Table 1 toward a given guest shows that 
M1 and 1 are comparable hosts in many cases (e.g. 6, 6DQ, 6Q, 13, 20). 
Interestingly, host M1 binds significantly stronger than 1 toward 11 (49-fold), 16 (19-
fold), 17 (8-fold), and 24 (8-fold). Guests 16, 17, and 24 all contain aromatic ring 
binding sites which suggests that the hydrophobic box defined by M1 is more 
appropriate for simultaneous edge-to-face and offset p-stacking with guests.102 We 
conclude that 1 is a surprisingly good host that is nearly on par with the prototypical 





In summary, we have reported the synthesis of host 1 which is based on a 
central glycoluril trimer capped with two triptycene sidewalls. Host 1 is water soluble 
(3 mM) and does not undergo strong self-association in water (Ks = 480). In solution, 
1 displays upfield chemical shifts for Hb of the triptycene sidewall (Figure III-5d) 
which indicates a self-folded conformation. In contrast, the X-ray crystal structure of 
1 displays two more open conformations where the triptycene sidewalls undergo an 
out-of-plane helical distortion. In combination the 1H NMR and X-ray results 
highlight the high conformational flexibility of 1 which stands in contrast to 
macrocyclic CB[n]. The geometries and thermodynamics of complexation between 1 
and guests 4–26 were elucidated by 1H NMR induced chemical shifts and measured 
by ITC. A subset of these Ka values form the blinded dataset for the SAMPL7 
challenge.147 We find that host 1 with its central glycoluril trimer is a superior host 
compared to previously synthesized host DimerTrip. Host 1 even displays Ka values 
toward many guests that are very close to those measured for M1 which is the 
prototypical acyclic CB[n]-type host. Finally, host 1 is a powerful receptor for 




Chapter 4: Acyclic Cucurbit[n]uril-Type Receptors: 
Optimization of Electrostatic Interactions for Dicationic Guests 
The work presented in this chapter was take from Lu, X.; Zebaze Ndendjio, S.; 
Zavalij, P.Y.; and Isaacs, L. Acyclic Cucurbit[n]uril-Type Receptors: Optimization of 
Electrostatic. Org Lett. 2020. In this work, Lu first developed the synthetic procedure 
of the direct sulfonation of the acyclic CB[n] host. I then repeated the synthesis of the 
host and conducted extensive NMR and ITC studies with various guest including 
drugs of abuse and Neuromuscular blocking agents.   
4.1 Introduction 
The preparation of molecular container compounds and their use in basic 
science and real world applications has been a focal point of research in 
supramolecular chemistry for several decades.10, 20, 34, 153  For example, cyclodextrin 
molecular containers have practical real world use as solubilizing excipients for 
hydrophobic drugs, as the active ingredient in the household product FebreezeTM, and 
as a sequestration agent for neuromuscular blockers in the form of Sugammadex.32  
cucurbit[n]uril molecular containers have become increasingly popular in the past 
decade due in part to their high affinity binding toward hydrophobic (di)cations (e.g. 
Ka commonly 106 M-1, often 109 M-1 and up to 1017 M-1 in select cases) and their 
stimuli responsive host•guest binding properties.20  CB[n] hosts are thereby well 
suited as components of functional systems (e.g. sensing ensembles, drug delivery 
systems, and supramolecular materials).10, 20  In recent years, we and others, have 




type receptors (e.g. M1, Scheme IV-1) which retain the essential binding properties 
of macrocyclic CB[n] but are more easily functionalized.95, 145  For example, M1 has 
been used as a solubilizing excipient for insoluble drugs and as in vivo sequestration 
agents for neuromuscular blockers (rocuronium, vecuronium, and cisatracurium) and 
drugs of abuse (e.g. methamphetamine and fentanyl).98  These applications require 
hosts with maximal binding affinities to allow them to outcompete the cognate 
biological receptors.32  Herein, we report the synthesis of host 1 whose anionic sulfate 
groups are positioned at the ureidyl C=O portals to complement cationic guests. 
Previously, we studied the influence of the alkylene (e.g. (CH2)n) linker length 
between the aromatic walls of acyclic CB[n] and the sulfonate solubilizing groups on 
their binding affinity toward guests but did not observe large differences for n = 2, 3, 
4.115  We reasoned that these alkylene linkers result in the anionic sulfonate groups 
being positioned away from the ureidyl carbonyl portal of M1, for example, and 
thereby reduce the electrostatic driving force toward guest complexation. 
Accordingly, we hypothesized that complete removal of the linker would position the 
negatively charged group closer to the cation binding site at the ureidyl carbonyl 
portal and thereby increase binding affinity toward cationic guests. 
4.2 Synthesis and characterization 
Synthetically, we allowed our key glycoluril tetramer building block (2)94 to 
react with hydroquinone (3) in TFA at room temperature to deliver hydroxylated host 
4 in 99% yield on a 20-gram scale.  Subsequently, 4 was allowed to react with 
pyridine-SO3 complex in pyridine at 90 ˚C to deliver host 1 in 60% yield on a 0.5-




characterized by spectroscopic means, but its structure was also confirmed by x-ray 
crystallographic measurements of its host•guest complexes (vide infra). For example, 
the 1H NMR spectrum of 1 shows six resonances for the diastereotopic methylene 
groups on the glycoluril oligomer backbone in the expected 4:4:4:4:2:2 ratio (Hb, Hc, 
Hd, He, Hf, Hg) along with a singlet for the aromatic H-atoms (Ha), two Me resonances 
(j and k), and two glycoluril methine resonances (Hh, Hi) which is consistent with the 
depicted C2v-symmetric structure of 1.   
 
Scheme IV-1. Synthesis of host 1.  Conditions: a) TFA, 25 ˚C, N2, 16 h; b) pyridine 
sulfur trioxide, pyridine, 90 ˚C, N2, 18 h. 
 
In the 13C NMR we observe all 14 resonances expected on the basis of the 
C2v-symmetric structure depicted for 1.  Finally, the electrospray ionization mass 
spectrum for 1 as its complex with guest 6d exhibits a doubly charged ion at m/z 
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exhibits very good solubility in water (>40 mM).  Before proceeding to investigate 
the host•guest properties of 1 we investigated its self-association properties to ensure 
that self-association does not impinge upon the planned binding constant 
measurements.34  Accordingly, we measured the 1H NMR spectrum for aqueous 
solutions of 1 upon dilution from 40 mM to 1 mM.  We did not observe any 
significant changes in chemical shifts (∆ẟ < 0.02 ppm) over this concentration range 
and therefore conclude that host 1 is monomeric in aqueous solution (Appendix 3). 
 
Figure IV-1. Cross eyed stereoviews of the x-ray crystal structures of a) 1•6d, and b) 
1•6a.  Color code: C, gray; H, white; N, blue; O, red; H-bonds red-yellow striped.  
 
We were fortunate to obtain the x-ray crystal structures of the 1•6d and 1•6a 
complexes (Figure IV-1).  Figure IV-1a shows the 1•6d complex adopts a geometry 
that optimizes Me3N+•••O=C electrostatic interactions at both portals and displays 
only small out-of-plane skewing of the terminal aromatic rings.  The geometry of 




distances cluster in the 3.810 – 4.690 Å range to spread the positive charge to the 
carbonyl portals.60 Quite interestingly, a second molecule of di-cationic guest 6d fits 
nicely into a cleft created by the aromatic sidewalls and the outward pointing OSO3ˉ 
groups to balance the overall 4- charges of host 1.  These OSO3ˉ groups also engage 
in electrostatic interactions with 6d with the Me3N+•••O-S shortest distances in the 
3.808 – 4.722 Å range.  The crystal structure of 1•6a (Figure IV-1) also shows one 
intracavity and one extra cavity molecule of 6a but displays significant out-of-plane 
twisting of the aromatic termini.  Interestingly, one of the four OSO3ˉ groups turns 
inward toward the ammonium ion guest which establishes that this group can directly 
participate in the guest recognition process. 
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Figure IV-2. Structures of guests 5 – 23 used in this study. 
 
Next, we performed qualitative host•guest binding studies of 1 with guests 5-
13 (Figure IV-2, Appendix 3) as monitored by 1H NMR spectroscopy.  Figure IV-3 
shows the 1H NMR spectra recorded for 1, 6d, and 1:1 and 1:2 mixtures of 1:6d.  As 
expected the methylene resonances for guest 6d (Hm, Hn, Ho) within the 1•6d complex 
(Figure IV-3b) experience a sizable upfield shift upon complexation due to the 
anisotropic shielding effects of the aromatic walls and the glycoluril concavity.45, 58  
At a 1:2 1:6d ratio, resonances are observed for both free 6d and 1•6d which indicates 
slow exchange on the 1H NMR chemical shift time scale which is usually observed 




the remainder of the guests (Appendix 3).  We find that the narrow guests (e.g. 11a, d 
and 6a-d) display slow exchange kinetics whereas the bulkier guests 12a,d display 
intermediate to fast ex-change on the chemical shift timescale.  We attribute this to 
their lower binding constants (vide infra) as a result of the expansion of the cavity of 
1 required to accommodate the larger adamantane framework 
 
Figure IV-3. 1H NMR spectra (D2O, 600 MHz) recorded for: a) 1 (1 mM), b) a 
mixture of 1 (1 mM) and 6d (1 mM), c) a mixture of 1 (1 mM) and 6d (2 mM), and d) 





4.4 Isothermal Titration Calorimetry 
Given the high binding constants typically observed for host•guest complexes 
of CB[n] and acyclic CB[n]-type receptors,95, 154 we elected to use isothermal titration 
calorimetry (ITC) to measure the Ka values between host 1 and guests 5 – 23.  For the 
weaker binding complexes (Ka ≤ 107 M-1), we performed the direct titration of host 1 
in the ITC cell with a solution of guest in the syringe and fitted the data to a 1:1 
binding model implemented by the PEAQ ITC software to obtain Ka and ∆H values 
(kcal mol-1).  Table IV-1 reports the thermodynamic data for 1•5, 1•6Q, 1•12a, 1•13a, 
1•14 – 1•18, and 1•21 – 1•23 that were obtained by direct ITC titrations (Appendix 
3).  Complexes with Ka values that exceed 107 M-1 cannot be measured accurately by 
direct titrations, so we turned to ITC competitive titrations.155  In competitive 
titrations, a solution of host and an excess of a weak guest of known ∆H and Ka is 
titrated with a solution of a tighter binding guest. Fitting of the heat released during 
the displacement process is analyzed by a competitive binding model in the PEAQ 
ITC data analysis software which delivers ∆H and Ka for the tighter binding complex.  
Figure IV-4a shows the thermogram recorded when a mixture of 1 and 13 was titrated 
with 6d and Figure IV-4b shows the fitting of the integrated heats to a competitive 
binding model to determine Ka = 6.79 × 109 M-1 and ∆H = -12.1 kcal mol-1.  Table 
IV-1 reports Ka and ∆H values for the remaining 1•guest complexes obtained in an 





Figure IV-4. a) Thermogram recorded during the titration of a mixture of 1 (100 µM) 
and 13 (2 mM) in the cell with a solution of 6d (1.0 mM) in the syringe, and b) fitting 
of the data to a competition binding model to extract Ka = 6.79 × 109 M-1 and ∆H = -
12.1 kcal mol-1. 
 
The binding constant data reported in Table IV-1 allows us to draw some 
conclusions about the molecular recognition preferences of host 1 in comparison to 
M1.  As expected, we find that the 1•guest complexes are uniformly driven by 
favorable enthalpic (∆H) contributions.  In the CB[n] series of hosts these favorable 
enthalpy values are attributed to the presence of high energy host intracavity water 
molecules that are released upon guest binding.57, 79 Host 1 displays high affinity 
toward hexane diammonium ion guests 6a – 6d with Kd values in the single digit nM 




over the primary – tertiary ammonium ions 6a – 6c.  In selected contexts, related 
preferences have been seen for CB[7]60 where they are attributed to the more efficient 
spreading of positive charge to the entire ureidyl C=O portal.  Host 1 binds 
quaternary monoammonium ion guest 6Q 890-fold weaker than the corresponding 
quaternary diammonium 6d; this ≈103 M-1 difference in affinity is also noted for 
CB[n]-type receptors.20  Importantly, we find that 1 binds to guests 6a – 6c 5.6 – 
11.9-fold stronger than M1, but 75-fold stronger than M1 toward bis(quaternary) 
guest 6d.  Similar preferences are observed for di-cationic guests 11a and 11d but not 
for mono-cationic guests 12a and 12d which suggests that the defined separation 
between OSO3ˉ groups in 1 makes it especially complementary to diammonium ion 
guests.  Host 1 also binds with high affinity (single digit nM to sub nM Kd values) 
toward the longer alkane di-ammonium ions 7d – 10d although 6d is the tightest 
binder in this series which reflects the ability of acyclic CB[n] to flex their cavity to 
accommodate larger guests and optimize binding affinity.  Related preferences have 
been seen for M1 and related receptors toward primary alkane diammonium ion 
guests previously.94 
 
Table IV-1.  Binding constants measured by ITC for host•guest complexes of 1.  
Comparative data for M1 are drawn from the literature.  Conditions: 20 mM sodium 
phosphate buffered H2O, pH 7.4, 25˚C. 
 Ka [M
-1]; ∆H (kcal mol-1) 
1 M1e) 
5 1.68 × 106; -6.76 ± 0.020a) – 
6a 3.70 × 108; -8.60 ± 0.021b) 5.05 × 107; -6.23 ± 0.014 
6b 5.26 × 108; -9.82 ± 0.038c) 9.43 × 107; -7.15 ± 0.025 
6c 5.74 × 108; -10.5 ± 0.028c) 4.81 × 107; -7.66 ± 0.073 
6d 6.71 × 109; -12.1 ± 0.042c) 8.93 × 107; -9.35 ± 0.021 




7d 6.06 × 109; -12.2 ± 0.041c) – 
8d 1.75 × 109; -10.5 ± 0.032c) – 
9d 7.57 × 108; -10.2 ± 0.030c) – 
10d 5.43 × 108; -10.3 ± 0.088c) – 
11a 9.71 × 108; -9.69 ± 0.014b) 1.67 × 108; -8.09 ± 0.018 
11d 1.05 × 109; -12.0 ± 0.030b) 1.78 × 108; -11.4 ± 0.022 
12a 9.90 × 105; -4.45 ± 0.021a) 9.62 × 105; -6.55 ± 0.029 
12d 6.66 × 106; -7.36 ± 0.030d) 1.70 × 107; -9.09 ± 0.027 
13a 3.41 × 106; -2.92 ± 0.019a) 1.95 × 106; -5.70 ± 0.027 
14 3.02 × 106; -9.28 ± 0.058a) 7.5 × 106 
15 3.64 × 106; -12.2 ± 0.076a) 1.1 × 107 
16 1.89 × 105; -6.18 ± 0.069a) 4.7 × 104 
17 7.69 × 105; -8.03 ± 0.07a) 5.3 × 105 
18 4.85 × 106; -5.90 ± 0.205a) – 
19 6.29 × 108; -12.9 ± 0.056b) 8.4 × 106 
20 1.00 × 109; -9.62 ± 0.036c) 5.8 × 106 
21 5.32 × 105; -15.4 ± 0.174a) 9.7 × 105 
22 2.41 × 104; -5.26 ± 0.372a) – 
23 2.31 × 105; -8.54 ± 0.063a) 2.4 × 104 
 
– not reported in the literature. a) Direct titration, b) competitive ITC with 5 as competitor, c) 
competitive ITC with 13a as competitor, d) competitive ITC with 6d as competitor, e) Taken from the 
literature. 6,12 
4.4.1 binding to drug of abuse 
Previously, we have shown that M1 and a naphthalene walled analogue 
known as M2 function as in vivo sequestration agents for drugs of abuse (e.g. 
methamphetamine (14)).156  Accordingly, we decided to measure the binding 
affinities of some compounds (14 – 18) relevant to counteracting the effects of drugs 
of abuse.  We find that host 1 binds less tightly than M1 toward 14 and 15.  In 
contrast, host 1 binds somewhat tighter to PCP (16) and morphine (17) than M1 does, 
but the single digit µM dissociation constants are unlikely to render 1 an efficient in 
vivo sequestration agent for  16 and 17.  Accordingly, 1 is not an improved lead 
compound for the sequestration of drugs of abuse (14 – 17).  This is perhaps not 
surprising given that 1 has a distinct preference for bis(quaternary) di-ammonium 




4.4.2 Serving as reversal agents for neuromuscular blocking molecules 
 In a separate line of inquiry, we have previously shown that M1 and M2 act 
as in vivo reversal agents for neuromuscular block induced by rocuronium (19), 
vecuronium (20), and cisatracurium (21).95, 129  Accordingly, we measured the 
binding constants of 1 toward a panel of compounds relevant to its potential use as an 
in vivo reversal agent.  Table 1 shows that 1 possesses higher binding affinity toward 
19 (75-fold) and 20 (172-fold) than M1 does.  Importantly, 1 binds >2700-fold tighter 
to 19 or 20 than to acetylcholine (23).  Acetylcholine is also present in the 
neuromuscular junction and must not be sequestered.  The affinity of 1•19 (6.29 × 108 
M-1) and 1•20 (1.00 × 109 M-1) are comparable to those of M2•19 (3.4 × 109 M-1) and 
M2•20 (1.6 × 109 M-1) which function very well in vivo.129  Host 1, however, 
possesses superior aqueous solubility (>40 mM) compared to M2 (18 mM) which 
might prove advantageous for formulation purposes. 
4.5 Conclusion 
In summary, we have presented the synthesis of a new acyclic CB[n]-type 
receptor (1) with OSO3ˉ groups directly connected to the aromatic walls.  Host 1 has 
excellent aqueous solubility (40 mM), does not undergo self-association, and binds 
more tightly to quaternary diammonium ions than analogue M1 that features 
propylene linking chains.  The X-ray crystal structures of 1•6a and 1•6d show the 
usual cavity encapsulation of the diammonium guest but also show an external 
diammonium ion that balances the overall charge of the tetra-anionic host 1.  In 
conclusion, we find that the negatively charged OSO3ˉ groups do not merely function 




of 1 results in enhanced binding affinity toward quaternary diammonium ions 
including important neuromuscular blocking agents (19 and 20).  This suggests that 1 






Chapter 5:  Conclusion 
Section 5.1 Summary 
Supramolecular concepts have been applied for molecular recognition, 
catalysis, drug delivery and reversal, solubilization, spectroscopic sensor probes, 
carbon nanotubes and more. The development of molecular containers has played a 
major role in this expansion. Molecular containers such as β-cyclodextrins are already 
used commercially for pharmaceutical purposes and industrial uses such as in 
FebreezeTM. The discovery of glycoluril based molecular containers such as 
cucurbit[n]urils and acyclic cucurbit[n]urls opened the door for more innovations. In 
particular, acyclic cucurbit[n]urils which display higher water solubility due to the 
sulfonate groups on its aromatic walls, it has a flexible backbone to encapsulate a 
wider variety of guests. The Isaacs research group did a tremendous work in studying 
and reporting the applications of acylic cucurbit[n]uril, M1 and M2, in solubilizing 
drugs, drug reversal toward neuromuscular blocking agents such as Rocuronium and 
Vecuronium, and recently, reversal of drugs such as Methamphetamine and Fentanyl. 
Chapter 2 described the yet another property of acyclic Cucubit[n]uril which 
is recognition properties toward amino acids, peptides and Insulin. It was found that 
acyclic CB[n] has high binding affinity toward amino acid amides due to ion-dipole 
interactions and hydrophobic effect. M1 and M2 show preferential binding affinity 
toward di-cationic and aromatic amino acid amides particularly phenylalanine amide. 
A deeper analysis shows the energetic cost or benefit in the formation of the 
complexation of acyclic CB[n] with amino acids or amino acid amides or amino 




guest. Like cucurbit[n]urils, the acyclic CB[n] can also bind to peptides however they 
are unable to encapsulate two amino acid residues at once. Finally, M1 and M2 show 
recognition ability toward Insulin in physiological conditions. 
 In chapter 3, a new acyclic CB[n] host – sulfonated trimer triptycene – was 
synthesized, characterized by spectroscopic methods, and its molecular recognition 
properties examined. An X-ray crystal structure of the host revealed its helical 
structure and an intriguing packing dynamic. This host displayed interesting 
recognition properties toward alkyl ammonium guests. It was found that the binding 
affinity increases as the length of the alkyl ammonium guest increases. The 
determined Ka values served as a blinded experimental dataset for the SAMPL series 
of challenges for computational chemists looking to improve their methods to 
calculate binding free energies in water.  Finally, the trimer triptycene host shows 
strong preferential binding affinity toward Fentanyl. 
 Chapter 4 introduced yet another acyclic CB[n] host, sulfate substituted 
acyclic CB[n] host. In this new host the alkyl linker connecting the aromatic ring to 
the sulfonate group is eliminated in order to optimize the binding affinity and 
selectivity of acyclic CB[n] toward guests. This new host displayed preferential 
binding affinity toward quaternary ammonium guests. Additionally, the new host 
demonstrated stronger binding affinity toward Rocuronium and Vecuronium than 
M1. This indicates its potential application as an in vivo reversal agent for 




Section 5.2 Future Work 
Acyclic cucurbit[n]uril hosts although they were just recently developed have 
already demonstrated outstanding applications in the field of pharmaceuticals. 
Although we have shown that M1 and M2 bind to a protein (Insulin) there are other 
proteins that could be targeted by acyclic CB[n].  For example, Klaerner and co-
workers have previously shown that benzonorbornene derived molecular tweezers 
can bind to amyloid protein and prevent aggregation. I suggest that it might be fruitful 
to perform a similar study with acyclic CB[n]s to evaluate their ability to binding to 
amyloid protein and their impact on aggregation in physiological conditions. Amyloid 
proteins are pertinent in the development of Alzheimer's disease which according to 
the National Institute of Health (NIH) affects over 5.5 million Americans over the age 




















































































Scheme V-I. Proposed synthesis of a new acyclic CB[n] 8 which would lead to 9.  
 
Another project to focus on for future work, is the synthesis of a new acyclic 
host which combined strong binding and selectivity toward quaternary guests and 
fluorescent sensing properties. To achieve this goal, host 8 can be obtained by 
reacting dihydroxy triptycene with glycoluril tetramer by double electrophilic 
aromatic substitution. Once 8 is obtained it can be transformed into 9 by reaction with 




Finally, a series of new sulfate hosts can be produced in order to complete the 
study of the impact of glycoluril backbone on the molecular recognition properties 
toward dicationic guests. Now that it is established that the sulfate substituted host 
with a glycoluril tetramer backbone has a strong binding affinity and selectivity 
toward quaternary ammonium guests. The new sulfate host 11 and 12 would have 
smaller cavities and would be selective toward smaller quaternary guests. Host 10 
with its trimer glycoluril backbone would most likely feature a helical structure which 
would allow it to bind to longer quaternary ammonium guests.  Accordingly, by 
creation of a library of acyclic CB[n] we should be able to optimize their binding 









































Figure V-1. Series of sulfate hosts composed of trimer sulfate host 10, dimer sulfate 
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General experimental details. The amino acid amides, amino acids, and acetyl 
amino amides were commercially available and obtained from Bachem, Chem-
Impex, Alfa Aeser, and Acros Organic. The acyclic CB[n] were synthesized, purified 
and characterized as described in a previous publication from the Isaacs group62. The 
tripeptides were commercially available and obtained from peptide2go and native 
human insulin recombinant from Saccharomyces cerevisiae (SAFC Biosciences). 
Calorimetric Titration using microcal PEAQ-ITC from Malvern were performed to 
obtain stability constants and reaction thermodynamics information for the formation 
of the complex between acyclic CB[n] and amino acid amides, amino acids and acetyl 
amino amides. Binding studies were also performed using 400 MHz 1H NMR at room 
temperature in 20 mM sodium phosphate (NaH2PO4) buffered D2O at pD 7.40 with 
64 scans.   
Details for Isothermal Titration Calorimetry (ITC) measurements.  All 
measurements were performed in High Performance Liquid Chromatography (HPLC) 
NaH2PO4 buffered water at pH 7.40. The Isothermal Titration Calorimetry (ITC) 
instrument were set at 19 injections with a volume of 2.00 μl per injections, 298.0 K 
temperature, with a reference power of 5.00 μcal/sec, stir speed of 750 rpm and the 
feedback was set on high. The measurements for Insulin and the three hosts were 
done in 20mM sodium phosphate buffered water (NaH2PO4) at pH 7.40, 4mM EDTA 





Figure II-S1.  Isothermal Titration Calorimetry (ITC) curve obtained when a solution 
of Motor 2 (100 μM) in the cell was titrated with Threonine amide (1.50 mM) in the 








Figure II-S2.  Isothermal Titration Calorimetry (ITC) curve obtained when a solution 
of Motor 2 (100 μM) in the cell was titrated with Serine amide (7.50 mM) in the 







Figure II-S3.  Isothermal Titration Calorimetry (ITC) curve obtained when a solution 
of Motor 2 (5.00 mM) in the cell was titrated with Glycine amide (50.0 mM) in the 








Figure II-S4.  Isothermal Titration Calorimetry (ITC) curve obtained when a solution 
of Motor 2 (100 μM) in the cell was titrated with Arginine amide (1.50 mM) in the 







Figure II-S5.  Isothermal Titration Calorimetry (ITC) curve obtained when a solution 
of Motor 2 (100 μM) in the cell was titrated with Glutamine amide (1.50 mM) in the 








Figure II-S6.  Isothermal Titration Calorimetry (ITC) curve obtained when a solution 
of Motor 2 (100 μM) in the cell was titrated with Leucine amide (1.00 mM) in the 







Figure II-S7.  Isothermal Titration Calorimetry (ITC) curve obtained when a solution 
of Motor 2 (5.00 mM) in the cell was titrated with Asparagine amide (50.0 mM) in 
the syringe at 298.0 K in 20 mM sodium phosphate buffered water at pH 7.4.  Ka= 






Figure II-S8.  Isothermal Titration Calorimetry (ITC) curve obtained when a solution 
of Motor 2 (100 μM) in the cell was titrated with Tyrosine amide (1.00 mM) in the 
syringe at 298.0 K in 20 mM sodium phosphate buffered water at pH 7.4.  Ka= 9.52 × 






Figure II-S9.  Isothermal Titration Calorimetry (ITC) curve obtained when a solution 
of Motor 2 (1.00 mM) in the cell was titrated with Valine amide (10.0 mM) in the 







Figure II-S10.  Isothermal Titration Calorimetry (ITC) curve obtained when a 
solution of Motor 2 (1.00 mM) in the cell was titrated with Proline amide (10.0 mM) 
in the syringe at 298.0 K in 20 mM sodium phosphate buffered water at pH 7.4.  Ka= 






Figure II-S11.  Isothermal Titration Calorimetry (ITC) curve obtained when a 
solution of Motor 2 (1.00 mM) in the cell was titrated with Histidine amide (10.0 
mM) in the syringe at 298.0 K in 20 mM sodium phosphate buffered water at pH 7.4.  






Figure II-S12.  Isothermal Titration Calorimetry (ITC) curve obtained when a 
solution of Motor 2 (100 μM) in the cell was titrated with Lysine amide (1.00 mM) in 
the syringe at 298.0 K in 20 mM sodium phosphate buffered water at pH 7.4.  Ka= 






Figure II-S13.  Isothermal Titration Calorimetry (ITC) curve obtained when a 
solution of Motor 2 (100 μM) in the cell was titrated with Methionine amide (1.50 
mM) in the syringe at 298.0 K in 20 mM sodium phosphate buffered water at pH 7.4.  






Figure II-S14.  Isothermal Titration Calorimetry (ITC) curve obtained when a 
solution of Motor 2 (100 μM) in the cell was titrated with Phenylalanine amide (1.00 
mM) in the syringe at 298.0 K in 20 mM sodium phosphate buffered water at pH 7.4.  






Figure II-S15.  Isothermal Titration Calorimetry (ITC) curve obtained when a 
solution of Motor 2 (100 μM) in the cell was titrated with Tryptophan amide (1.20 
mM) in the syringe at 298.0 K in 20 mM sodium phosphate buffered water at pH 7.4.  






Figure II-S16.  Isothermal Titration Calorimetry (ITC) curve obtained when a 
solution of Motor 2 (100 μM) in the cell was titrated with Aspartic acid amide (1.50 
mM) in the syringe at 298.0 K in 20 mM sodium phosphate buffered water at pH 7.4.  






Figure II-S17.  Isothermal Titration Calorimetry (ITC) curve obtained when a 
solution of Motor 2 (100 μM) in the cell was titrated with Isoleucine amide (1.00 
mM) in the syringe at 298.0 K in 20 mM sodium phosphate buffered water at pH 7.4.  






Figure II-S18.  Isothermal Titration Calorimetry (ITC) curve obtained when a 
solution of Motor 2 (5.00 mM) in the cell was titrated with Alanine amide (1.00 × 102 
mM) in the syringe at 298.0 K in 20 mM sodium phosphate buffered water at pH 7.4.  






Figure II-S19.  Isothermal Titration Calorimetry (ITC) curve obtained when a 
solution of Motor 2 (100 μM) in the cell was titrated with Glutamic amide (1.50 mM) 
in the syringe at 298.0 K in 20 mM sodium phosphate buffered water at pH 7.4.  Ka= 






Figure II-S20.  Isothermal Titration Calorimetry (ITC) curve obtained when a 
solution of Motor 1 (1.00 mM) in the cell was titrated with Proline amide (10.0 mM) 
in the syringe at 298.0 K in 20 mM sodium phosphate buffered water at pH 7.4.  Ka= 






Figure II-S21.  Isothermal Titration Calorimetry (ITC) curve obtained when a 
solution of Motor 1 (2.00 mM) in the cell was titrated with Serine amide (18.5 mM) 
in the syringe at 298.0 K in 20 mM sodium phosphate buffered water at pH 7.4.  Ka= 






Figure II-S22.  Isothermal Titration Calorimetry (ITC) curve obtained when a 
solution of Motor 1 (1.00 mM) in the cell was titrated with Valine amide (10.0 mM) 
in the syringe at 298.0 K in 20 mM sodium phosphate buffered water at pH 7.4.  Ka= 






Figure II-S23.  Isothermal Titration Calorimetry (ITC) curve obtained when a 
solution of Motor 1 (100 μM) in the cell was titrated with Glutamic amide (1.50 mM) 
in the syringe at 298.0 K in 20 mM sodium phosphate buffered water at pH 7.4.  Ka= 






Figure II-S24.  Isothermal Titration Calorimetry (ITC) curve obtained when a 
solution of Motor 1 (5.00 mM) in the cell was titrated with Glycine amide (50.0 mM) 
in the syringe at 298.0 K in 20 mM sodium phosphate buffered water at pH 7.4.  Ka= 






Figure II-S25.  Isothermal Titration Calorimetry (ITC) curve obtained when a 
solution of Motor 1 (100 μM) in the cell was titrated with Threonine amide (4 mM) in 
the syringe at 298.0 K in 20 mM sodium phosphate buffered water at pH 7.4.  Ka= 






Figure II-S26.  Isothermal Titration Calorimetry (ITC) curve obtained when a 
solution of Motor 1 (1.00 mM) in the cell was titrated with Glutamine amide (25.0 
mM) in the syringe at 298.0 K in 20 mM sodium phosphate buffered water at pH 7.4.  






Figure II-S27.  Isothermal Titration Calorimetry (ITC) curve obtained when a 
solution of Motor 1 (5.00 mM) in the cell was titrated with Alanine amide (1.00 × 102 
mM) in the syringe at 298.0 K in 20 mM sodium phosphate buffered water at pH 7.4.  






Figure II-S28.  Isothermal Titration Calorimetry (ITC) curve obtained when a 
solution of Motor 1 (100 μM) in the cell was titrated with Arginine amide (1.50 mM) 
in the syringe at 298.0 K in 20 mM sodium phosphate buffered water at pH 7.4.  Ka= 






Figure II-S29.  Isothermal Titration Calorimetry (ITC) curve obtained when a 
solution of Motor 1 (200 μM) in the cell was titrated with Asparagine amide (5 mM) 
in the syringe at 298.0 K in 20 mM sodium phosphate buffered water at pH 7.4.  Ka= 






Figure II-S30.  Isothermal Titration Calorimetry (ITC) curve obtained when a 
solution of Motor 1 (100 μM) in the cell was titrated with Aspartic acid amide (1.50 
mM) in the syringe at 298.0 K in 20 mM sodium phosphate buffered water at pH 7.4.  






Figure II-S31.  Isothermal Titration Calorimetry (ITC) curve obtained when a 
solution of Motor 1 (100 μM) in the cell was titrated with Tyrosine amide (1.00 mM) 
in the syringe at 298.0 K in 20 mM sodium phosphate buffered water at pH 7.4.  Ka= 






Figure II-S32.  Isothermal Titration Calorimetry (ITC) curve obtained when a 
solution of Motor 1 (100 μM) in the cell was titrated with Isoleucine amide (1.50 
mM) in the syringe at 298.0 K in 20 mM sodium phosphate buffered water at pH 7.4.  






Figure II-S33.  Isothermal Titration Calorimetry (ITC) curve obtained when a 
solution of Motor 1 (100 μM) in the cell was titrated with Methionine amide (1.50 
mM) in the syringe at 298.0 K in 20 mM sodium phosphate buffered water at pH 7.4.  







Figure II-S34.  Isothermal Titration Calorimetry (ITC) curve obtained when a 
solution of Motor 1 (100 μM) in the cell was titrated with Lysine amide (1.50 mM) in 
the syringe at 298.0 K in 20 mM sodium phosphate buffered water at pH 7.4.  Ka= 






Figure II-S35.  Isothermal Titration Calorimetry (ITC) curve obtained when a 
solution of Motor 1 (250 μM) in the cell was titrated with Histidine amide (3.00 mM) 
in the syringe at 298.0 K in 20 mM sodium phosphate buffered water at pH 7.4.  Ka= 






Figure II-S36.  Isothermal Titration Calorimetry (ITC) curve obtained when a 
solution of Motor 1 (100 μM) in the cell was titrated with Tryptophan amide (1.50 
mM) in the syringe at 298.0 K in 20 mM sodium phosphate buffered water at pH 7.4.  






Figure II-S37.  Isothermal Titration Calorimetry (ITC) curve obtained when a 
solution of Motor 1 (100 μM) in the cell was titrated with Leucine amide (1.50 mM) 
in the syringe at 298.0 K in 20 mM sodium phosphate buffered water at pH 7.4.  Ka= 






Figure II-S38.  Isothermal Titration Calorimetry (ITC) curve obtained when a 
solution of Motor 2 (100 μM) in the cell was titrated with Acetyl-phenylalanine 
amide (1.00 mM) in the syringe at 298.0 K in 20 mM sodium phosphate buffered 






Figure II-S39.  Isothermal Titration Calorimetry (ITC) curve obtained when a 
solution of Motor 2 (1.00 mM) in the cell was titrated with Acetyl-Lysine amide (20.0 
mM) in the syringe at 298.0 K in 20 mM sodium phosphate buffered water at pH 7.4.  






Figure II-S40.  Isothermal Titration Calorimetry (ITC) curve obtained when a 
solution of Motor 2 (100 μM) in the cell was titrated with Acetyl-Tryptophan amide 
(2.00 mM) in the syringe at 298.0 K in 20 mM sodium phosphate buffered water at 






Figure II-S41.  Isothermal Titration Calorimetry (ITC) curve obtained when a 
solution of Acetyl- Tyrosine amide (1.00 mM) in the cell was titrated with Motor 2 
(20.0 mM) in the syringe at 298.0 K in 20 mM sodium phosphate buffered water at 






Figure II-S42.  Isothermal Titration Calorimetry (ITC) curve obtained when a 
solution of Motor 2 (1.00 mM) in the cell was titrated with Acetyl-Arginine amide 
(20.0 mM) in the syringe at 298.0 K in 20 mM sodium phosphate buffered water at 






Figure II-S43.  Isothermal Titration Calorimetry (ITC) curve obtained when a 
solution of Motor 1 (1.00 mM) in the cell was titrated with Acetyl-Lysine amide (20.0 
mM) in the syringe at 298.0 K in 20 mM sodium phosphate buffered water at pH 7.4.  






Figure II-S44.  Isothermal Titration Calorimetry (ITC) curve obtained when a 
solution of Motor 1 (1.00 mM) in the cell was titrated with Acetyl-Tryptophan amide 
(10.0 mM) in the syringe at 298.0 K in 20 mM sodium phosphate buffered water at 






Figure II-S45.  Isothermal Titration Calorimetry (ITC) curve obtained when a 
solution of Acetyl- Tyrosine amide (1.00 mM) in the cell was titrated with Motor 1 
(10.0 mM) in the syringe at 298.0 K in 20 mM sodium phosphate buffered water at 






Figure II-S46.  Isothermal Titration Calorimetry (ITC) curve obtained when a 
solution of Motor 1 (1.00 mM) in the cell was titrated with Acetyl-Phenylalanine 
amide (20.0 mM) in the syringe at 298.0 K in 20 mM sodium phosphate buffered 






Figure II-S47.  Isothermal Titration Calorimetry (ITC) curve obtained when a 
solution of Motor 1 (1.00 mM) in the cell was titrated with Acetyl-Arginine amide 
(20.0 mM) in the syringe at 298.0 K in 20 mM sodium phosphate buffered water at 






Figure II-S48.  Isothermal Titration Calorimetry (ITC) curve obtained when a 
solution of Motor 2 (5.00 mM) in the cell was titrated with Lysine (50.00 mM) in the 







Figure II-S49.  Isothermal Titration Calorimetry (ITC) curve obtained when a 
solution of Motor 2 (1.00 mM) in the cell was titrated with phenylalanine (15.00 mM) 
in the syringe at 298.0 K in 20 mM sodium phosphate buffered water at pH 7.4.  Ka = 






Figure II-S50.  Isothermal Titration Calorimetry (ITC) curve obtained when a 
solution of Motor 2 (1.00 mM) in the cell was titrated with Tryptophan (10.00 mM) 
in the syringe at 298.0 K in 20 mM sodium phosphate buffered water at pH 7.4.  Ka =  






Figure II-S51.  Isothermal Titration Calorimetry (ITC) curve obtained when a 
solution of Tyrosine (1.00 mM) in the cell was titrated with Motor 2 (20.0 mM) in the 
syringe at 298.0 K in 20 mM sodium phosphate buffered water at pH 7.4.  Ka = 2.03 






Figure II-S52.  Isothermal Titration Calorimetry (ITC) curve obtained when a 
solution of Motor 2 (5.00 mM) in the cell was titrated with Arginine (50.0 mM) in the 
syringe at 298.0 K in 20 mM sodium phosphate buffered water at pH 7.4.  Ka = 2.39 






Figure II-S53.  Isothermal Titration Calorimetry (ITC) curve obtained when a 
solution of Motor 1 (5.00 mM) in the cell was titrated with Lysine (40.0 mM) in the 







Figure II-S54.  Isothermal Titration Calorimetry (ITC) curve obtained when a 
solution of Motor 1 (1.00 mM) in the cell was titrated with Tryptophan (15.00 mM) 
in the syringe at 298.0 K in 20 mM sodium phosphate buffered water at pH 7.4.  Ka = 






Figure II-S55.  Isothermal Titration Calorimetry (ITC) curve obtained when a 
solution of Tyrosine (1.00 mM) in the cell was titrated with Motor 1 (20.0 mM) in the 
syringe at 298.0 K in 20 mM sodium phosphate buffered water at pH 7.4.  Ka = 1.01 






Figure II-S56.  Isothermal Titration Calorimetry (ITC) curve obtained when a 
solution of Motor 1 (1.00 mM) in the cell was titrated with Phenylalanine (10.0 mM) 
in the syringe at 298.0 K in 20 mM sodium phosphate buffered water at pH 7.4.  Ka = 






Figure II-S57.  Isothermal Titration Calorimetry (ITC) curve obtained when a 
solution of Motor 1 (2.00 mM) in the cell was titrated with Arginine (50.00 mM) in 
the syringe at 298.0 K in 20 mM sodium phosphate buffered water at pH 7.4.  Ka = 






Figure II-S58.  Isothermal Titration Calorimetry (ITC) curve obtained when a 
solution of H-Phe-Gly-Ala-NH2 (100 μM) in the cell was titrated with Motor 2 (1.00 
mM) in the syringe at 298.0 K in 20 mM sodium phosphate buffered water at pH 7.4.  






Figure II-S59.  Isothermal Titration Calorimetry (ITC) curve obtained when a 
solution of Motor 2 (100 μM) in the cell was titrated with H-Phe-Pro-Ala-NH2 (1.00 
mM) in the syringe at 298.0 K in 20 mM sodium phosphate buffered water at pH 7.4.  






Figure II-S60.  Isothermal Titration Calorimetry (ITC) curve obtained when a 
solution of H-Phe-Ile-Ala-NH2 (100 μM) in the cell was titrated with Motor 2 (1.00 
mM) in the syringe at 298.0 K in 20 mM sodium phosphate buffered water at pH 7.4.  






Figure II-S61.  Isothermal Titration Calorimetry (ITC) curve obtained when a 
solution of Motor 2 (100 μM) in the cell was titrated with H-Phe-Phe-Ala-NH2 (1.00 
mM) in the syringe at 298.0 K in 20 mM sodium phosphate buffered water at pH 7.4.  






Figure II-S62.  Isothermal Titration Calorimetry (ITC) curve obtained when a 
solution of H-Phe-Leu-Ala-NH2 (100 μM) in the cell was titrated with Motor 2 (1.00 
mM) in the syringe at 298.0 K in 20 mM sodium phosphate buffered water at pH 7.4.  






Figure II-S63.  Isothermal Titration Calorimetry (ITC) curve obtained when a 
solution of H-Phe-Lys-Ala-NH2 (100 μM) in the cell was titrated with Motor 2 (1.00 
mM) in the syringe at 298.0 K in 20 mM sodium phosphate buffered water at pH 7.4.  






Figure II-S64.  Isothermal Titration Calorimetry (ITC) curve obtained when a 
solution of H-Phe-Val-Ala-NH2 (100 μM) in the cell was titrated with Motor 2 (1.00 
mM) in the syringe at 298.0 K in 20 mM sodium phosphate buffered water at pH 7.4.  






Figure II-S65.  Isothermal Titration Calorimetry (ITC) curve obtained when a 
solution of H-Phe-Gly-Ala-NH2 (100 μM) in the cell was titrated with Motor 1 (1.00 
mM) in the syringe at 298.0 K in 20 mM sodium phosphate buffered water at pH 7.4.  






Figure II-S66.  Isothermal Titration Calorimetry (ITC) curve obtained when a 
solution of H-Phe-Pro-Ala-NH2 (100 μM) in the cell was titrated with Motor 1 (1.00 
mM) in the syringe at 298.0 K in 20 mM sodium phosphate buffered water at pH 7.4.  






Figure II-S67.  Isothermal Titration Calorimetry (ITC) curve obtained when a 
solution of H-Phe-Phe-Ala-NH2 (100 μM) in the cell was titrated with Motor 1 (1.00 
mM) in the syringe at 298.0 K in 20 mM sodium phosphate buffered water at pH 7.4.  






Figure II-S68.  Isothermal Titration Calorimetry (ITC) curve obtained when a 
solution of H-Phe-Leu-Ala-NH2 (100 μM) in the cell was titrated with Motor 1 (1.00 
mM) in the syringe at 298.0 K in 20 mM sodium phosphate buffered water at pH 7.4.  






Figure II-S69.  Isothermal Titration Calorimetry (ITC) curve obtained when a 
solution of H-Phe-Ile-Ala-NH2 (100 μM) in the cell was titrated with Motor 1 (1.00 
mM) in the syringe at 298.0 K in 20 mM sodium phosphate buffered water at pH 7.4.  






Figure II-S70.  Isothermal Titration Calorimetry (ITC) curve obtained when a 
solution of H-Phe-Lys-Ala-NH2 (100 μM) in the cell was titrated with Motor 1 (1.00 
mM) in the syringe at 298.0 K in 20 mM sodium phosphate buffered water at pH 7.4.  






Figure II-S71.  Isothermal Titration Calorimetry (ITC) curve obtained when a 
solution of H-Phe-Val-Ala-NH2 (100 μM) in the cell was titrated with Motor 1 (1.00 
mM) in the syringe at 298.0 K in 20 mM sodium phosphate buffered water at pH 7.4.  






Figure II-S72.  Isothermal Titration Calorimetry (ITC) curve obtained when a 
solution of Insulin (200 μM) in the cell was titrated with CB [7] (2.00 mM) in the 
syringe at 298.0 K in 20 mM sodium phosphate buffered water at pH 7.4 containing 4 






Figure II-S73.  Isothermal Titration Calorimetry (ITC) curve obtained when a 
solution of Insulin (200 μM) in the cell was titrated with Motor 2 (2.00 mM) in the 
syringe at 298.0 K in 20 mM sodium phosphate buffered water at pH 7.4 containing 






Figure II-S74.  Isothermal Titration Calorimetry (ITC) curve obtained when a 
solution of Insulin (200 μM) in the cell was titrated with Motor 1 (2.00 mM) in the 
syringe at 298.0 K in 20 mM sodium phosphate buffered water at pH 7.4 containing 






Figure II-S75. 1H NMR spectra recorded (D2O, 400 MHz, RT) for: a) Isoleucine 
amide (2 mM), b) a mixture of Motor 1 (1 mM) and Isoleucine amide (2 mM), c) a 
mixture of Motor 1 (1 mM) and Isoleucine amide (1.5 mM), d) a mixture of Motor 1 
(1 mM) and Isoleucine amide (1 mM), e) a mixture of Motor 1 (1 mM) and Isoleucine 






Figure II-S76.  1H NMR spectra recorded (D2O, 400 MHz, RT) for: a) Lysine amide 
(2 mM), b) a mixture of Motor 1 (1 mM) and Lysine amide (2 mM), c) a mixture of 
Motor 1 (1 mM) and Lysine amide (1.5 mM), d) a mixture of Motor 1 (1 mM) and 
Lysine amide (1 mM), e) a mixture Motor 1 (1 mM) and Lysine amide (0.5 mM), f) 






Figure II-S77.  1H NMR spectra recorded (D2O, 400 MHz, RT) for: a) Proline amide 
(2 mM), b) a mixture of Motor 1 (1 mM) and Proline amide (2 mM), c) a mixture of 
Motor 1 (1 mM) and Proline amide (1.5 mM), d) a mixture of Motor 1 (1 mM) and 
Proline amide (1 mM), e) a mixture Motor 1 (1 mM) and Proline amide (0.5 mM), f) 






Figure II-S78.  1H NMR spectra recorded (D2O, 400 MHz, RT) for: a) Alanine 
amide (2 mM), b) a mixture of Motor 1 (1 mM) and Alanine amide (2 mM), c) a 
mixture of Motor 1 (1 mM) and Alanine amide (1.5 mM), d) a mixture of Motor 1 (1 
mM) and Alanine amide (1 mM), e) a mixture Motor 1 (1 mM) and Alanine amide 






Figure II-S79.  1H NMR spectra recorded (D2O, 400 MHz, RT) for: a) Serine amide 
(2 mM), b) a mixture of Motor 1 (1 mM) and Serine amide (2 mM), c) a mixture of 
Motor 1 (1 mM) and Serine amide (1.5 mM), d) a mixture of Motor 1 (1 mM) and 
Serine amide (1 mM), e) a mixture of Motor 1 (1 mM) and Serine amide (0.5 mM), f) 






Figure II-S80. 1H NMR spectra recorded (D2O, 400 MHz, RT) for: a) Glutamic acid 
amide (2 mM), b) a mixture of Motor 1 (1 mM) and Glutamic acid amide (2 mM), c) 
a mixture of Motor 1 (1 mM) and Glutamic acid amide (1.5 mM), d) a mixture of 
Motor 1 (1 mM) and Glutamic acid amide (1 mM), e) a mixture of Motor 1 (1 mM) 






Figure II-S81. 1H NMR spectra recorded (D2O, 400 MHz, RT) for: a) Glycine amide 
(3 mM), b) a mixture of Motor 1 (1 mM) and Glycine amide (2 mM), c) a mixture of 
Motor 1 (1 mM) and Glycine amide (1.5 mM), d) a mixture of Motor 1 (1 mM) and 
Glycine amide (1 mM), e) a mixture of Motor 1 (1 mM) and Glycine amide (0.5 






Figure II-S82. 1H NMR spectra recorded (D2O, 400 MHz, RT) for: a) Valine amide 
(10 mM), b) a mixture of Motor 1 (1 mM) and Valine amide (2 mM), c) a mixture of 
Motor 1 (1 mM) and Valine amide (1.5 mM), d) a mixture of Motor 1 (1 mM) and 
Valine amide (1 mM), e) a mixture of Motor 1 (1 mM) and Valine amide (0.5 mM), f) 






Figure II-S83. 1H NMR spectra recorded (D2O, 400 MHz, RT) for: a) Leucine amide 
(2 mM), b) a mixture of Motor 1 (1 mM) and Leucine amide (2 mM), c) a mixture of 
Motor 1 (1 mM) and Leucine amide (1.5 mM), d) a mixture of Motor 1 (1 mM) and 
Leucine amide (1 mM), e) a mixture of Motor 1 (1 mM) and Leucine amide (0.5 






Figure II-S84. 1H NMR spectra recorded (D2O, 400 MHz, RT) for: a) Tryptophan 
amide (2 mM), b) a mixture of Motor 1 (1 mM) and Tryptophan amide (2 mM), c) a 
mixture of Motor 1 (1 mM) and Tryptophan amide (1.5 mM), d) a mixture of Motor 1 
(1 mM) and Tryptophan amide (1 mM), e) a mixture of Motor 1 (1 mM) and 






Figure II-S85. 1H NMR spectra recorded (D2O, 400 MHz, RT) for: a) Tyrosine 
amide (10 mM), b) a mixture of Motor 1 (1 mM) and Tyrosine amide (2 mM), c) a 
mixture of Motor 1 (1 mM) and Tyrosine amide (1.5 mM), d) a mixture of Motor 1 (1 
mM) and Tyrosine amide (1 mM), e) a mixture of Motor 1 (1 mM) and Tyrosine 






Figure II-S86. 1H NMR spectra recorded (D2O, 400 MHz, RT) for: a) Glutamine 
amide (2 mM), b) a mixture of Motor 1 (1 mM) and Glutamine amide (2 mM), c) a 
mixture of Motor 1 (1 mM) and Glutamine amide (1.5 mM), d) a mixture of Motor 1 
(1 mM) and Glutamine amide (1 mM), e) a mixture of Motor 1 (1 mM) and 






Figure II-S87. 1H NMR spectra recorded (D2O, 400 MHz, RT) for: a) Methionine 
amide (2 mM), b) a mixture of Motor 1 (1 mM) and Methionine amide (2 mM), c) a 
mixture of Motor 1 (1 mM) and Methionine amide (1.5 mM), d) a mixture of Motor 1 
(1 mM) and Methionine amide (1 mM), e) a mixture of Motor 1 (1 mM) and 






Figure II-S88. 1H NMR spectra recorded (D2O, 400 MHz, RT) for: a) Histidine 
amide (2 mM), b) a mixture of Motor 1 (1 mM) and Histidine amide (2 mM), c) a 
mixture of Motor 1 (1 mM) and Histidine amide (1.5 mM), d) a mixture of Motor 1 (1 
mM) and Histidine amide (1 mM), e) a mixture of Motor 1 (1 mM) and Histidine 






Figure II-S89. 1H NMR spectra recorded (D2O, 400 MHz, RT) for: a) Threonine 
amide (2 mM), b) a mixture of Motor 1 (1 mM) and Threonine amide (2 mM), c) a 
mixture of Motor 1 (1 mM) and Threonine amide (1.5 mM), d) a mixture of Motor 1 
(1 mM) and Threonine amide (1 mM), e) a mixture of Motor 1 (1 mM) and Threonine 






Figure II-S90. 1H NMR spectra recorded (D2O, 400 MHz, RT) for: a) Aarginine 
amide (2 mM), b) a mixture of Motor 1 (1 mM) and Arginine amide (2 mM), c) a 
mixture of Motor 1 (1 mM) and Arginine amide (1.5 mM), d) a mixture of Motor 1 (1 
mM) and Arginine amide (1 mM), e) a mixture of Motor 1 (1 mM) and Arginine 






Figure II-S91. 1H NMR spectra recorded (D2O, 400 MHz, RT) for: a) Aspartic acid 
amide (2 mM), b) a mixture of Motor 1 (1 mM) and Aspartic acid amide (2 mM), c) a 
mixture of Motor 1 (1 mM) and Arginine amide (1.5 mM), d) a mixture of Motor 1 (1 
mM) and Aspartic acid amide (1 mM), e) a mixture of Motor 1 (1 mM) and Aspartic 






Figure II-S92. 1H NMR spectra recorded (D2O, 400 MHz, RT) for: a) Asparagine 
amide (2 mM), b) a mixture of Motor 1 (1 mM) and Asparagine amide (2 mM), c) a 
mixture of Motor 1 (1 mM) and Asparagine amide (1.5 mM), d) a mixture of Motor 1 
(1 mM) and Asparagine amide (1 mM), e) a mixture of Motor 1 (1 mM) and 






Figure II-S93.  1H NMR spectra recorded (D2O, 400 MHz, RT) for: a) Tryptophan 
amide (2 mM), b) a mixture of Motor 2 (1 mM) and Tryptophan amide (2 mM), c) a 
mixture of Motor 2 (1 mM) and Tryptophan amide (1.5 mM), d) a mixture of Motor 2 
(1 mM) and Tryptophan amide (1 mM), e) a mixture of Motor 2 (1 mM) and 






Figure II-S94.  1H NMR spectra recorded (D2O, 400 MHz, RT) for: a) Valine amide 
(10 mM), b) a mixture of Motor 2 (1 mM) and Valine amide (2 mM), c) a mixture of 
Motor 2 (1 mM) and Valine amide (1.5 mM), d) a mixture of Motor 2 (1 mM) and 
Valine amide (1 mM), e) a mixture of Motor 2 (1 mM) and Valine amide (0.5 mM), f) 







Figure II-S95.  1H NMR spectra recorded (D2O, 400 MHz, RT) for: a) Asparagine 
amide (2 mM), b) a mixture of Motor 2 (1 mM) and Asparagine amide (2 mM), c) a 
mixture of Motor 2 (1 mM) and Asparagine amide (1.5 mM), d) a mixture of Motor 2 
(1 mM) and Asparagine amide (1 mM), e) a mixture of Motor 2 (1 mM) and 






Figure II-S96.  1H NMR spectra recorded (D2O, 400 MHz, RT) for: a) Tyrosine 
amide (10 mM), b) a mixture of Motor 2 (1 mM) and Tyrosine amide (2 mM), c) a 
mixture of Motor 2 (1 mM) and Tyrosine amide (1.5 mM), d) a mixture of Motor 2 (1 
mM) and Tyrosine amide (1 mM), e) a mixture of Motor 2 (1 mM) and Tyrosine 






Figure II-S97.  1H NMR spectra recorded (D2O, 400 MHz, RT) for: a) Glutamine 
amide (2 mM), b) a mixture of Motor 2 (1 mM) and Glutamine amide (2 mM), c) a 
mixture of Motor 2 (1 mM) and Glutamine amide (1.5 mM), d) a mixture of Motor 2 
(1 mM) and Glutamine amide (1 mM), e) a mixture of Motor 2 (1 mM) and 






Figure II-S98.  1H NMR spectra recorded (D2O, 400 MHz, RT) for: a) Glutamic acid 
amide (2 mM), b) a mixture of Motor 2 (1 mM) and Glutamic acid amide (2 mM), c) 
a mixture of Motor 2 (1 mM) and Glutamic acid amide (1.5 mM), d) a mixture of 
Motor 2 (1 mM) and Glutamic acid amide (1 mM), e) a mixture of Motor 2 (1 mM) 






Figure II-S99.  1H NMR spectra recorded (D2O, 400 MHz, RT) for: a) Alanine 
amide (2 mM), b) a mixture of Motor 2 (1 mM) and Alanine amide (2 mM), c) a 
mixture of Motor 2 (1 mM) and Alanine amide (1.5 mM), d) a mixture of Motor 2 (1 
mM) and Alanine amide (1 mM), e) a mixture of Motor 2 (1 mM) and Alanine amide 






Figure II-S100.  1H NMR spectra recorded (D2O, 400 MHz, RT) for: a) Aspartic acid 
amide (2 mM), b) a mixture of Motor 2 (1 mM) and Aspartic acid amide (2 mM), c) a 
mixture of Motor 2 (1 mM) and Aspartic acid amide (1.5 mM), d) a mixture of Motor 
2 (1 mM) and Aspartic acid amide (1 mM), e) a mixture of Motor 2 (1 mM) and 






Figure II-S101.  1H NMR spectra recorded (D2O, 400 MHz, RT) for: a) Leucine 
amide (2 mM), b) a mixture of Motor 2 (1 mM) and Leucine amide (2 mM), c) a 
mixture of Motor 2 (1 mM) and Leucine amide (1.5 mM), d) a mixture of Motor 2 (1 
mM) and Leucine amide (1 mM), e) a mixture of Motor 2 (1 mM) and Leucine amide 






Figure II-S102.  1H NMR spectra recorded (D2O, 400 MHz, RT) for: a) Isoleucine 
amide (2 mM), b) a mixture of Motor 2 (1 mM) and Isoleucine amide (2 mM), c) a 
mixture of Motor 2 (1 mM) and Isoleucine amide (1.5 mM), d) a mixture of Motor 2 
(1 mM) and Isoleucine amide (1 mM), e) a mixture of Motor 2 (1 mM) and Isoleucine 






Figure II-S103.  1H NMR spectra recorded (D2O, 400 MHz, RT) for: a) Glycine 
amide (3 mM), b) a mixture of Motor 2 (1 mM) and Glycine amide (2 mM), c) a 
mixture of Motor 2 (1 mM) and Glycine amide (1.5 mM), d) a mixture of Motor 2 (1 
mM) and Glycine amide (1 mM), e) a mixture of Motor 2 (1 mM) and Glycine amide 






Figure II-S104.  1H NMR spectra recorded (D2O, 400 MHz, RT) for: a) Serine amide 
(2 mM), b) a mixture of Motor 2 (1 mM) and Serine amide (2 mM), c) a mixture of 
Motor 2 (1 mM) and Serine amide (1.5 mM), d) a mixture of Motor 2 (1 mM) and 
Serine amide (1 mM), e) a mixture of Motor 2 (1 mM) and Serine amide (0.5 mM), f) 






Figure II-S105.  1H NMR spectra recorded (D2O, 400 MHz, RT) for: a) Proline 
amide (2 mM), b) a mixture of Motor 2 (1 mM) and Proline amide (2 mM), c) a 
mixture of Motor 2 (1 mM) and Proline amide (1.5 mM), d) a mixture of Motor 2 (1 
mM) and Proline amide (1 mM), e) a mixture of Motor 2 (1 mM) and Proline amide 






Figure II-S106.  1H NMR spectra recorded (D2O, 400 MHz, RT) for: a) Threonine 
amide (2 mM), b) a mixture of Motor 2 (1 mM) and Threonine amide (2 mM), c) a 
mixture of Motor 2 (1 mM) and Threonine amide (1.5 mM), d) a mixture of Motor 2 
(1 mM) and Threonine amide (1 mM), e) a mixture of Motor 2 (1 mM) and Threonine 






Figure II-S107. 1H NMR spectra recorded (D2O, 400 MHz, RT) for: a) Methionine 
amide (2 mM), b) a mixture of Motor 2 (1 mM) and Methionine amide (2 mM), c) a 
mixture of Motor 2 (1 mM) and Methionine amide (1.5 mM), d) a mixture of Motor 2 
(1 mM) and Methionine amide (1 mM), e) a mixture of Motor 2 (1 mM) and 






Figure II-S108.  1H NMR spectra recorded (D2O, 400 MHz, RT) for: a) Lysine 
amide (2 mM), b) a mixture of Motor 2 (1 mM) and Lysine amide (2 mM), c) a 
mixture of Motor 2 (1 mM) and Lysine amide (1.5 mM), d) a mixture of Motor 2 (1 
mM) and Lysine amide (1 mM), e) a mixture of Motor 2 (1 mM) and Lysine amide 






Figure II-S109. 1H NMR spectra recorded (D2O, 400 MHz, RT) for: a) Histidine 
amide (2 mM), b) a mixture of Motor 2 (1 mM) and Histidine amide (2 mM), c) a 
mixture of Motor 2 (1 mM) and Histidine amide (1.5 mM), d) a mixture of Motor 2 (1 
mM) and Histidine amide (1 mM), e) a mixture of Motor 2 (1 mM) and Histidine 






Figure II-S110.  1H NMR spectra recorded (D2O, 400 MHz, RT) for: a) Arginine 
amide (2 mM), b) a mixture of Motor 2 (1 mM) and Arginine amide (2 mM), c) a 
mixture of Motor 2 (1 mM) and Arginine amide (1.5 mM), d) a mixture of Motor 2 (1 
mM) and Arginine amide (1 mM), e) a mixture of Motor 2 (1 mM) and Arginine 






Figure II-S111. 1H NMR spectra recorded (D2O , 400 MHz, RT) for: a) Acetyl 
phenylalanine amide (2 mM), b) a mixture of Motor 1 (1 mM) and Acetyl 
phenylalanine amide (2 mM ), c) a mixture of Motor 1 (1 mM) and Acetyl 
phenylalanine amide (1.5 mM), d) a mixture of Motor 1 (1 mM) and Acetyl 
phenylalanine amide (1 mM), e) a mixture of Motor 1 (1 mM ) and Acetyl 






Figure II-S112.  1H NMR spectra recorded (D2O , 400 MHz, RT) for: a) Acetyl 
arginine amide (2 mM), b) a mixture of Motor 1 (1 mM) and Acetyl arginine amide 
(2 mM ), c) a mixture of Motor 1 (1 mM) and Acetyl arginine amide (1.5 mM), d) a 
mixture of Motor 1 (1 mM) and Acetyl arginine amide (1 mM), e) a mixture of Motor 






Figure II-S113.  1H NMR spectra recorded (D2O , 400 MHz, RT) for: a) Acetyl 
tryptophan amide (2 mM), b) a mixture of Motor 1 (1 mM) and Acetyl tryptophan 
amide (2 mM ), c) a mixture of Motor 1 (1 mM) and Acetyl tryptophan amide (1.5 
mM), d) a mixture of Motor 1 (1 mM) and Acetyl tryptophan amide (1 mM), e) a 
mixture of Motor 1 (1 mM ) and Acetyl tryptophan amide (0.5 mM ), f) Motor 1 (1 






Figure II-S114. 1H NMR spectra recorded (D2O , 400 MHz, RT) for: a) Acetyl 
tyrosine amide (2 mM), b) a mixture of Motor 1 (1 mM) and Acetyl tyrosine amide (2 
mM ), c) a mixture of Motor 1 (1 mM) and Acetyl tyrosine amide (1.5 mM), d) a 
mixture of Motor 1 (1 mM) and Acetyl tyrosine amide (1 mM), e) a mixture of Motor 






Figure II-S115.  1H NMR spectra recorded (D2O , 400 MHz, RT) for: a) Acetyl 
lysine amide (2 mM), b) a mixture of Motor 1 (1 mM) and Acetyl lysine amide (2 
mM ), c) a mixture of Motor 1 (1 mM) and Acetyl lysine amide (1.5 mM), d) a 
mixture of Motor 1 (1 mM) and Acetyl lysine amide (1 mM), e) a mixture of Motor 1 






Figure II-S116.  1H NMR spectra recorded (D2O , 400 MHz, RT) for: a) Acetyl 
lysine amide (2 mM), b) a mixture of Motor 2 (1 mM) and Acetyl lysine amide (2 
mM ), c) a mixture of Motor 2 (1 mM) and Acetyl lysine amide (1.5 mM), d) a 
mixture of Motor 2 (1 mM) and Acetyl lysine amide (1 mM), e) a mixture of Motor 2 






Figure II-S117.  1H NMR spectra recorded (D2O , 400 MHz, RT) for: a) Acetyl 
tyrosine amide (2 mM), b) a mixture of Motor 2 (1 mM) and Acetyl tyrosine amide (2 
mM ), c) a mixture of Motor 2 (1 mM) and Acetyl tyrosine amide (1.5 mM), d) a 
mixture of Motor 2 (1 mM) and Acetyl tyrosine amide (1 mM), e) a mixture of Motor 






Figure II-S118.  1H NMR spectra recorded (D2O , 400 MHz, RT) for: a) Acetyl 
arginine amide (2 mM), b) a mixture of Motor 2 (1 mM) and Acetyl arginine amide 
(2 mM ), c) a mixture of Motor 2 (1 mM) and Acetyl arginine amide (1.5 mM), d) a 
mixture of Motor 2 (1 mM) and Acetyl arginine amide (1 mM), e) a mixture of Motor 






Figure II-S119.  1H NMR spectra recorded (D2O , 400 MHz, RT) for: a) Acetyl 
phenylalanine amide (2 mM), b) a mixture of Motor 2 (1 mM) and Acetyl 
phenylalanine amide (2 mM ), c) a mixture of Motor 2 (1 mM) and Acetyl 
phenylalanine amide (1.5 mM), d) a mixture of Motor 2 (1 mM) and Acetyl 
phenylalanine amide (1 mM), e) a mixture of Motor 2 (1 mM ) and Acetyl 






Figure II-S120. 1H NMR spectra recorded (D2O , 400 MHz, RT) for: a) Acetyl 
tryptophan amide (2 mM), b) a mixture of Motor 2 (1 mM) and Acetyl tryptophan 
amide (2 mM ), c) a mixture of Motor 2 (1 mM) and Acetyl tryptophan amide (1.5 
mM), d) a mixture of Motor 2 (1 mM) and Acetyl tryptophan amide (1 mM), e) a 
mixture of Motor 2 (1 mM ) and Acetyl tryptophan amide (0.5 mM ), f) Motor 2 (5 






Figure II-S121.  1H NMR spectra recorded (D2O , 400 MHz, RT) for: a) 
Phenylalanine (2 mM), b) a mixture of Motor 1 (1 mM) and phenylalanine (2 mM ), 
c) a mixture of Motor 1 (1 mM) and phenylalanine (1.5 mM), d) a mixture of Motor 1 
(1 mM) and phenylalanine (1 mM), e) a mixture of Motor 1 (1 mM ) and 






Figure II-S122.  1H NMR spectra recorded (D2O , 400 MHz, RT) for: a) Lysine (2 
mM), b) a mixture of Motor 1 (1 mM) and lysine (2 mM ), c) a mixture of Motor 1 (1 
mM) and lysine (1.5 mM), d) a mixture of Motor 1 (1 mM) and lysine (1 mM), e) a 






Figure II-S123. 1H NMR spectra recorded (D2O , 400 MHz, RT) for: a) Tryptophan 
(2 mM), b) a mixture of Motor 1 (1 mM) and tryptophan (2 mM ), c) a mixture of 
Motor 1 (1 mM) and tryptophan (1.5 mM), d) a mixture of Motor 1 (1 mM) and 
tryptophan (1 mM), e) a mixture of Motor 1 (1 mM ) and tryptophan (0.5 mM ), f) 






Figure II-S124. 1H NMR spectra recorded (D2O , 400 MHz, RT) for: a) Tyrosine (2 
mM), b) a mixture of Motor 1 (1 mM) and tyrosine (2 mM ), c) a mixture of Motor 1 
(1 mM) and tyrosine (1.5 mM), d) a mixture of Motor 1 (1 mM) and tyrosine (1 mM), 






Figure II-S125. 1H NMR spectra recorded (D2O , 400 MHz, RT) for: a) Arginine (2 
mM), b) a mixture of Motor 1 (1 mM) and arginine (2 mM ), c) a mixture of Motor 1 
(1 mM) and arginine (1.5 mM), d) a mixture of Motor 1 (1 mM) and arginine (1 mM), 







Figure II-S126.  1H NMR spectra recorded (D2O , 400 MHz, RT) for: a) Lysine (2 
mM), b) a mixture of Motor 2 (1 mM) and lysine (2 mM ), c) a mixture of Motor 2 (1 
mM) and lysine (1.5 mM), d) a mixture of Motor 2 (1 mM) and lysine (1 mM), e) a 






Figure II-S127.  1H NMR spectra recorded (D2O , 400 MHz, RT) for: a) 
Phenylalanine (2 mM), b) a mixture of Motor 2 (1 mM) and phenylalanine (2 mM ), 
c) a mixture of Motor 2 (1 mM) and phenylalanine (1.5 mM), d) a mixture of Motor 2 
(1 mM) and phenylalanine (1 mM), e) a mixture of Motor 2 (1 mM ) and 






Figure II-S128.  1H NMR spectra recorded (D2O , 400 MHz, RT) for: a) Tryptophan 
(2 mM), b) a mixture of Motor 2 (1 mM) and tryptophan (2 mM ), c) a mixture of 
Motor 2 (1 mM) and tryptophan (1.5 mM), d) a mixture of Motor 2 (1 mM) and 
tryptophan (1 mM), e) a mixture of Motor 2 (1 mM ) and tryptophan (0.5 mM ), f) 






Figure II-S129. 1H NMR spectra recorded (D2O , 400 MHz, RT) for: a) Arginine (2 
mM), b) a mixture of Motor 2 (1 mM) and arginine (2 mM ), c) a mixture of Motor 2 
(1 mM) and arginine (1.5 mM), d) a mixture of Motor 2 (1 mM) and arginine (1 mM), 






Figure II-S130. 1H NMR spectra recorded (D2O , 400 MHz, RT) for: a) Tyrosine (2 
mM), b) a mixture of Motor 2 (1 mM) and tyrosine (2 mM ), c) a mixture of Motor 2 
(1 mM) and tyrosine (1.5 mM), d) a mixture of Motor 2 (1 mM) and tyrosine (1 mM), 
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Starting materials were purchased from commercial suppliers and used without 
further purification or were prepared by literature procedures.  Melting points were 
measured on a Meltemp apparatus in open capillary tubes and are uncorrected. IR 
spectra were recorded on a JASCO FT/IR 4100 spectrometer and are reported in cm-1.  
NMR spectra were measured on Bruker spectrometers operating at 400 or 600 MHz 
for 1H and 100 or 125 MHz for 13C using D2O, or DMSO-d6 as solvents. Chemical 
shifts (δ) are referenced relative to the residual resonances for HOD (4.80 ppm) and 
DMSO-d6 (2.50 ppm for 1H, 39.51 ppm for 13C). Mass spectrometry was performed 
using a JEOL AccuTOF electrospray instrument (ESI).  ITC data was collected on a 
Malvern Microcal PEAQ-ITC instrument and analyzed using the software provided 





1H and 13C NMR spectra of host 1 
 
 
Figure III-S1. 1H NMR spectrum (D2O, 20 mM sodium phosphate, pD 7.4, 600 












Figure III-S3. 13C NMR spectrum (D2O, 600 MHz, RT, 1,4-dioxane as internal 




1H NMR Dilution Experiments Performed for host 1 
Self-association Binding Model implemented in ScientistTM 
// Micromath Scientist Model File 
// self-association model for NMR 
IndVars: concTot 
DepVars: Deltaobs 
Params: Ka, Deltasat, Deltazero 
Ka = concBound/(concFree*concFree) 
concTot=concFree + concBound/2 
Deltaobs = Deltazero + (Deltasat - Deltazero) * (1/2*concBound/concTot) 
//Constraints 
0 < Ka 
0 < concFree < concTot 







Figure III-S4. 1H NMR spectra recorded (D2O, 20 mM sodium phosphate, pD 7.40, 
600 MHz, RT) for the dilution of host 1 (3 - 0.05 mM). Host 1 weakly self-associates 
in water (Ks = 480 ± 81 M-1). 






Figure III-S5. 1H NMR spectra recorded (D2O, 20 mM sodium phosphate, pD 7.40, 
400 MHz, RT) for: a) 4 (5 mM), b) a mixture of 1 (125 µM) and 4 (250 µM), c) a 






Figure III-S6. 1H NMR spectra recorded (D2O, 20 mM sodium phosphate, pD 7.40, 
600 MHz, RT) for: a) 5 (5 mM), b) a mixture of 1 (250 µM) and 5 (500 µM), c) a 







Figure III-S7. 1H NMR spectra recorded (D2O, 20 mM sodium phosphate, pD 7.40, 
600 MHz, RT) for: a) 6 (5 mM), b) a mixture of 1 (250 µM) and 6 (500 µM), c) a 






Figure III-S8. 1H NMR spectra recorded (D2O, 20 mM sodium phosphate, pD 7.40, 
600 MHz, RT) for: a) 6DQ•2Br- (6 mM), b) a mixture of 1 (250 µM) and 6DQ•2Br- 






Figure III-S9. 1H NMR spectra recorded (D2O, 20 mM sodium phosphate, pD 7.40, 
400 MHz, RT) for: a) 6Q•Br- (4 mM), b) a mixture of 1 (125 µM) and 6Q•Br- (250 






Figure III-S10. 1H NMR spectra recorded (D2O, 20 mM sodium phosphate, pD 7.40, 
600 MHz, RT) for: a) 7 (2 mM), b) a mixture of 1 (125 µM) and 7 (250 µM), c) a 






Figure III-S11. 1H NMR spectra recorded (D2O, 20 mM sodium phosphate, pD 7.40, 
600 MHz, RT) for: a) 9 (2 mM), b) a mixture of 1 (125 µM) and 9 (250 µM), c) a 






Figure III-S12. 1H NMR spectra recorded (D2O, 20 mM sodium phosphate, pD 7.40, 
600 MHz, RT) for: a) 10 (2 mM), b) a mixture of 1 (125 µM) and 10 (250 µM), c) a 






Figure III-S13. 1H NMR spectra recorded (D2O, 20 mM sodium phosphate, pD 7.40, 
600 MHz, RT) for: a) 11 (5 mM), b) a mixture of 1 (250 µM) and 11 (500 µM), c) a 






Figure III-S14. 1H NMR spectra recorded (D2O, 20 mM sodium phosphate, pD 7.40, 
400 MHz, RT) for: a) 12 (2 mM), b) a mixture of 1 (125 µM) and 12 (250 µM), c) a 






Figure III-S15. 1H NMR spectra recorded (D2O, 20 mM sodium phosphate, pD 7.40, 
600 MHz, RT) for: a) 13 (2 mM), b) a mixture of 1 (125 µM) and 13 (250 µM), c) a 






Figure III-S16. 1H NMR spectra recorded (D2O, 20 mM sodium phosphate, pD 7.40, 
600 MHz, RT) for: a) 14 (4 mM), b) a mixture of 1 (125 µM) and 14 (250 µM), c) a 






Figure III-S17. 1H NMR spectra recorded (D2O, 20 mM sodium phosphate, pD 7.40, 
600 MHz, RT) for: a) 15 (4 mM), b) a mixture of 1 (250 µM) and 15 (500 µM), c) a 






Figure III-S18. 1H NMR spectra recorded (D2O, 20 mM sodium phosphate, pD 7.40, 
600 MHz, RT) for: a) 16 (4 mM), b) a mixture of 1 (250 µM) and 16 (500 µM), c) a 






 Figure III-S19. 1H NMR spectra recorded (D2O, 20 mM sodium phosphate, pD 
7.40, 600 MHz, RT) for: a) 17 (2 mM), b) a mixture of 1 (250 µM) and 17 (500 µM), 






Figure III-S20. 1H NMR spectra recorded (D2O, 20 mM sodium phosphate, pD 7.40, 
600 MHz, RT) for: a) 18 (1 mM), b) a mixture of 1 (125 µM) and 18 (250 µM), c) a 






Figure III-S21. 1H NMR spectra recorded (D2O, 20 mM sodium phosphate, pD 7.40, 
600 MHz, RT) for: a) 19 (4 mM), b) a mixture of 1 (250 µM) and 19 (500 µM), c) a 






Figure III-S22. 1H NMR spectra recorded (D2O, 20 mM sodium phosphate, pD 7.40, 
600 MHz, RT) for: a) 20 (250 µM), b) a mixture of 1 (125 µM) and 20 (250 µM), c) a 






Figure III-S23. 1H NMR spectra recorded (D2O, 20 mM sodium phosphate, pD 7.40, 
600 MHz, RT) for: a) 21 (1 mM), b) a mixture of 1 (125 µM) and 21 (250 µM), c) a 






Figure III-S24. 1H NMR spectra recorded (D2O, 20 mM sodium phosphate, pD 7.40, 
600 MHz, RT) for: a) 22 (2 mM), b) a mixture of 1 (125 µM) and 22 (250 µM), c) a 






Figure III-S25. 1H NMR spectra recorded (D2O, 20 mM sodium phosphate, pD 7.40, 
600 MHz, RT) for: a) 23 (250 µM), b) a mixture of 1 (125 µM) and 23 (250 µM), c) a 






Figure III-S26. 1H NMR spectra recorded (D2O, 20 mM sodium phosphate, pD 7.40, 
400 MHz, RT) for: a) 24 (250 µM), b) a mixture of 1 (125 µM) and 24 (250 µM), c) a 







Figure III-S27. 1H NMR spectra recorded (D2O, 20 mM sodium phosphate, pD 7.40, 
600 MHz, RT) for: a) 25 (1 mM), b) a mixture of 1 (125 µM) and 25 (250 µM), c) a 






Figure III-S28. 1H NMR spectra recorded (D2O, 20 mM sodium phosphate, pD 7.40, 
600 MHz, RT) for: a) 26 (250 mM), b) a mixture of 1 (62.5 µM) and 26 (125 µM), c) 




Isotherm of guests (4-26) with host 1 
 
 
Figure III-S29.  Isothermal Titration Calorimetry (ITC) curve obtained when a 
solution of 1 (100 μM) in the cell was titrated with 4 (1.00 mM) in the syringe at 
298.0 K in 20 mM sodium phosphate buffered water at pH 7.4.  Ka = 2.92 × 104 M-1 






Figure III-S30.  Isothermal Titration Calorimetry (ITC) curve obtained through 
competition binding studies. A solution of 1 (100 μM) and 19 (500 µM) in the cell 
was titrated with 6 (1.00 mM) in the syringe at 298.0 K in 20 mM sodium phosphate 







Figure III-S31.  Isothermal Titration Calorimetry (ITC) curve obtained through 
competition binding studies. A solution of 1 (100 μM) and 19 (500 µM) in the cell 
was titrated with 6DQ (1.00 mM) in the syringe at 298.0 K in 20 mM sodium 







Figure III-S32.  Isothermal Titration Calorimetry (ITC) curve obtained when a 
solution of 1 (100 μM) in the cell was titrated with 6Q (1.00 mM) in the syringe at 
298.0 K in 20 mM sodium phosphate buffered water at pH 7.4.  Ka =   1.20 × 106 M-1 






Figure III-S33.  Isothermal Titration Calorimetry (ITC) curve obtained through 
competition binding studies. A solution of 1 (100 μM) and 19 (500 µM) in the cell 
was titrated with 7 (1.00 mM) in the syringe at 298.0 K in 20 mM sodium phosphate 






Figure III-S34.  Isothermal Titration Calorimetry (ITC) curve obtained through 
competition binding studies. A solution of 1 (100 μM) and 5 (500 µM) in the cell was 
titrated with 8 (1.00 mM) in the syringe at 298.0 K in 20 mM sodium phosphate 






Figure III-S35.  Isothermal Titration Calorimetry (ITC) curve obtained through 
competition binding studies. A solution of 1 (100 μM) and 5 (500 µM) in the cell was 
titrated with 9 (1.00 mM) in the syringe at 298.0 K in 20 mM sodium phosphate 






Figure III-S36.  Isothermal Titration Calorimetry (ITC) curve obtained through 
competition binding studies. A solution of 1 (100 μM) and 5 (200 µM) in the cell was 
titrated with 10 (1.00 mM) in the syringe at 298.0 K in 20 mM sodium phosphate 






Figure III-S37. Isothermal Titration Calorimetry (ITC) curve obtained when a 
solution of 1 (100 μM) in the cell was titrated with 11 (1.00 mM) in the syringe at 
298.0 K in 20 mM sodium phosphate buffered water at pH 7.4.  Ka = 3.57 × 105 M-1 






Figure III-S38.  Isothermal Titration Calorimetry (ITC) curve obtained through 
competition binding studies. A solution of 1 (100 μM) and 5 (500 µM) in the cell was 
titrated with 12 (1.00 mM) in the syringe at 298.0 K in 20 mM sodium phosphate 






Figure III-S39.  Isothermal Titration Calorimetry (ITC) curve obtained when a 
solution of 1 (10.0 μM) in the cell was titrated with 13 (100 µM) in the syringe at 
298.0 K in 20 mM sodium phosphate buffered water at pH 7.4.  Ka = 1.13 × 107 M-1 






Figure III-S40.  Isothermal Titration Calorimetry (ITC) curve obtained when a 
solution of 1 (20.0 μM) in the cell was titrated with 14 (200 µM) in the syringe at 
298.0 K in 20 mM sodium phosphate buffered water at pH 7.4.  Ka = 4.08 × 106 M-1 







Figure III-S41. Isothermal Titration Calorimetry (ITC) curve obtained when a 
solution of 1 (100 μM) in the cell was titrated with 15 (1.00 mM) in the syringe at 
298.0 K in 20 mM sodium phosphate buffered water at pH 7.4.  Ka = 1.11 × 106 M-1 






Figure III-S42. Isothermal Titration Calorimetry (ITC) curve obtained through 
competition binding studies. A solution of 1 (100 μM) and 19 (500 µM) in the cell 
was titrated with 16 (1.00 mM) in the syringe at 298.0 K in 20 mM sodium phosphate 






Figure III-S43. Isothermal Titration Calorimetry (ITC) curve obtained through 
competition binding studies. A solution of 1 (100 μM) and 19 (500 µM) in the cell 
was titrated with 17 (1.00 mM) in the syringe at 298.0 K in 20 mM sodium phosphate 






Figure III-S44. Isothermal Titration Calorimetry (ITC) curve obtained through 
competition binding studies. A solution of 1 (100 μM) and 5 (500 µM) in the cell was 
titrated with 18 (1.00 mM) in the syringe at 298.0 K in 20 mM sodium phosphate 






Figure III-S45.  Isothermal Titration Calorimetry (ITC) curve obtained when a 
solution of 1 (100 μM) in the cell was titrated with 19 (1.00 mM) in the syringe at 
298.0 K in 20 mM sodium phosphate buffered water at pH 7.4. Ka = 5.95 × 104 M-1 






Figure III-S46. Isothermal Titration Calorimetry (ITC) curve obtained through 
competition binding studies. A solution of 1 (100 μM) and 19 (500 µM) in the cell 
was titrated with 20 (1.00 mM) in the syringe at 298.0 K in 20 mM sodium phosphate 






Figure III-S47.  Isothermal Titration Calorimetry (ITC) curve obtained when a 
solution of 1 (100 μM) in the cell was titrated with 21 (1.00 mM) in the syringe at 
298.0 K in 20 mM sodium phosphate buffered water at pH 7.4. Ka = 9.80 × 104 M-1 






Figure III-S48. Isothermal Titration Calorimetry (ITC) curve obtained when a 
solution of 1 (200 μM) in the cell was titrated with 22 (5.00 mM) in the syringe at 
298.0 K in 20 mM sodium phosphate buffered water at pH 7.4. Ka = 5.61 × 104 M-1 







Figure III-S49. Isothermal Titration Calorimetry (ITC) curve obtained when a 
solution of 1 (100 μM) in the cell was titrated with 23 (1.00 mM) in the syringe at 
298.0 K in 20 mM sodium phosphate buffered water at pH 7.4. Ka = 8.47 × 103 M-1 







Figure III-S50. Isothermal Titration Calorimetry (ITC) curve obtained when a 
solution of 1 (100 μM) in the cell was titrated with 24 (1.00 mM) in the syringe at 
298.0 K in 20 mM sodium phosphate buffered water at pH 7.4. Ka = 9.43 × 105 M-1 







Figure III-S51. Isothermal Titration Calorimetry (ITC) curve obtained when a 
solution of 1 (100 μM) in the cell was titrated with 25 (2.00 mM) in the syringe at 
298.0 K in 20 mM sodium phosphate buffered water at pH 7.4. Ka = 3.70 × 104 M-1 






Figure III-S52. Isothermal Titration Calorimetry (ITC) curve obtained when a 
solution of 1 (200 μM) in the cell was titrated with 26 (2.40 mM) in the syringe at 
298.0 K in 20 mM sodium phosphate buffered water at pH 7.4. Ka = 4.67 × 103 M-1 









Figure III-S53. Electrospray mass spectrum for 1 recorded in the negative ion mode. 
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All chemicals and reagents were purchased from commercial suppliers and were used 
without further purification.  Compound 2 was prepared as described previously.1 
NMR spectra were measured at 400, 500 or 600 MHz for 1H and 100 and 125 MHz 
for 13C. The solvent for NMR experiments was deuterated water (D2O), deuterated 
chloroform (CDCl3), or deuterated dimethyl sulfoxide (DMSO-d6). Chemical shifts 
(δ) are referenced relative to the residual resonances for HOD (4.80 ppm), CHCl3 
(7.26 ppm for 1H, 77.16 ppm for 13C), DMSO-d6 (2.50 ppm for 1H, 39.51 ppm for 
13C). Isothermal titration calorimetry was performed using a MicroCal PEAQ-ITC 
Isothermal Titration Calorimeter using 20 mM phosphate buffered water at pH = 7.4 
at 298 K. Mass spectrometry was performed using a JEOL AccuTOF electrospray 
instrument. Melting points were measured by a Meltemp apparatus in open capillary 
tubes and are uncorrected. IR spectra were measured on a Thermo Nicolet NEXUS 
670 FT/IR spectrometer by attenuated total reflectance (ATR) and are reported in cm -
1. 
 
1. Ma, D.; Hettiarachchi, G.; Nguyen, D.; Zhang, B.; Wittenberg, J. B.; Zavalij, P. Y.; 































Synthesis and characterization of compounds 4 and 1. 
 
Container 4. To a mixture of glycoluril tetramer bisether 2 (17 g, 22.1 mmol) and 
hydroquinone (9.7 g, 88.2 mmol) was added trifluoroacetic acid (300 mL). The 
resulting heterogeneous mixture was stirred under N2 at 25 °C for 16 hours. The 
reaction mixture was then poured into MeOH (600 mL) and stirred for 1 hour. The 
crude product was collected by filtration and subsequently washed with MeOH (400 
mL), acetone (300 mL) and water (400 mL) to remove the unreacted hydroquinone. 
The residue was dried under the high vacuum to yield 2 as a pale-yellow solid (20.8 
g, yield 99%). M.p. > 300 °C, IR (ATR, cm-1): 3400w, 1713s, 1460s, 1226s, 1082m, 
971w, 797s.  1H NMR (DMSO-d6, 600 MHz): δ 8.60 (s, 4H), 6.55 (s, 4H), 5.56 (d, J 
= 14.5 Hz, 2H), 5.49 (d, J = 15.1 Hz, 4H), 5.38 (d, J = 8.9 Hz, 2H), 5.27 (d, J = 8.9 
Hz, 2H), 5.18 (d, J = 15.7 Hz, 4H), 4.09 – 4.04 (m, 10H), 1.68 (s, 6H), 1.62 (s, 6H). 
13C NMR (DMSO-d6, 125 MHz): δ 155.3, 154.2, 147.0, 126.1, 116.7, 77.4, 76.4, 
70.7, 70.3, 48.1, 35.0, 17.1, 15.8 ppm (13 out of the 14 expected resonances were 
observed). HR-MS (ESI, positive, para-xylenediammonium dichloride as guest): m/z 
551.22446 ([M + guest- 2Cl-]2+), C50H58N18O12 2+ calcd. for 551.22408.  
 
Container 1.  To a mixture of compound 2 (0.80 g, 0.83 mmol) and pyridine sulfur 
trioxide complex (2.6 g, 16.3 mmol) was added dry pyridine (25 mL). The resulting 
mixture was stirred at 90 °C under N2 for 18 hours. The reaction mixture was cooled 
to RT. The product precipitated out of the solution and was collected by filtration. 
The solid was slurried in water (1 mL), and the pH was adjusted to 8.4 by slow 
addition of saturated aqueous NaHCO3. After addition of EtOH (70 mL), the crude 
product was collected by centrifugation 7000 rpm × 7 min. The precipitate was 
suspended in ethanol (50 mL × 2), sonicated for 30 minutes, and solid collected by 
centrifugation. The crude solid was analyzed by NMR and process was repeated until 
the trapped pyridine was fully removed. Then the pH of the crude solution was 
adjusted to 7.0 by slow addition of 1 M HCl and the solvent was evaporated. The 
crude solid was treated with 30 mL of a mixture of CH3CN/ H2O (2: 1) and the 
heterogeneous mixture was centrifuged, the supernatant was collected and then 
evaporated to give a crude solid. The crude solid was redissolved in minimum amount 
of water and purified by size exclusion chromatography using Sephadex® G25 resin 
(30mm x 200mm) and eluted by water. Pure product was collected as the front 
fractions with violet fluorescent color under UV long wavelength (366 nm). After 
drying under high vacuum, the compound 1 was obtained as a light-yellow solid (0.50 
g, 60% yield). M.p. > 300 °C, IR (ATR, cm-1): 1720m, 1468s, 1228s, 1048s, 970m, 
798s. 1H NMR (D2O, 500 MHz): δ 7.53 (s, 4H), 6.66 (d, J = 15.4 Hz, 2H), 5.57 (d, J 
= 15.8 Hz, 4H), 5.46 (d, J = 8.9 Hz, 2H), 5.41 (d, J = 8.9 Hz, 2H), 5.28 (d, J = 16.5 
Hz, 4H), 4.41 (d, J = 16.5 Hz, 4H), 4.29 (d, J = 15.8 Hz, 4H), 4.16 (d, J = 15.4 Hz, 
2H), 1.84 (s, 6H), 1.82 (s, 6H). 13C NMR (D2O, 125 MHz, dioxane as external 
reference): δ 156.5, 155.9, 146.0, 131.9, 123.0, 78.3, 77.3, 71.1, 70.9, 52.5, 48.1, 
35.8, 15.6, 14.6 ppm (14 out of the 14 expected resonances were observed). HR-MS 
(ESI, positive, 6d as guest): m/z 787.1679 ([M + 6d-2Cl-]2+), C54H70N18O24Na42+ 



































Figure IV-S4. 13C DEPT135 NMR spectra (600 MHz, D2O, RT) recorded for 





























Figure IV-S8. 1H NMR spectra (600 MHz, D2O, RT) recorded for  a) host 1 (1.0 
mM), b) host 1 (1.0 mM) and guest 5a (1.0 mM), c) host 1 (1.0 mM) and guest 5a 






Figure IV-S9. 1H NMR spectra (600 MHz, D2O, RT) recorded for  a) host 1 (1.0 
mM), b) host 1 (1.0 mM) and guest 6Q (1.0 mM), c) host 1 (1.0 mM) and guest 6Q 







Figure IV-S10. 1H NMR spectra (600 MHz, D2O, RT) recorded for a) host 1 (1.0 
mM), b) host 1 (1.0 mM) and guest 11d (1.0 mM), c) host 1 (1.0 mM) and guest 11d 






Figure IV-S11. 1H NMR spectra (600 MHz, D2O, RT) recorded for a) host 1 (1.0 
mM), b) host 1 (1.0 mM) and guest 11a (1.0 mM), c) host 1 (1.0 mM) and guest 11a 






Figure IV-S12. 1H NMR spectra (600 MHz, D2O, RT) recorded for a) host 1 (1.0 
mM), b) host 1 (1.0 mM) and guest 6d (1.0 mM), c) host 1 (1.0 mM) and guest 6d 






Figure IV-S13. 1H NMR spectra (600 MHz, D2O, RT) recorded for a) host 1 (1.0 
mM), b) host 1 (1.0 mM) and guest 6c (1.0 mM), c) host 1 (1.0 mM) and guest 6c 







Figure IV-S14. 1H NMR spectra (600 MHz, D2O, RT) recorded for a) host 1 (1.0 
mM), b) host 1 (1.0 mM) and guest 6b (1.0 mM), c) host 1 (1.0 mM) and guest 6b 







Figure IV-S15. 1H NMR spectra (600 MHz, D2O, RT) recorded for a) host 1 (1.0 
mM), b) host 1 (1.0 mM) and guest 6a (1.0 mM), c) host 1 (1.0 mM) and guest 6a 






Figure IV-S16. 1H NMR spectra (600 MHz, D2O, RT) recorded for a) host 1 (1.0 
mM), b) host 1 (1.0 mM) and guest 7d (1.0 mM), c) host 1 (1.0 mM) and guest 7d 






Figure IV-S17. 1H NMR spectra (600 MHz, D2O, RT) recorded for a) host 1 (1.0 
mM), b) host 1 (1.0 mM) and guest 8d (1.0 mM), c) host 1 (1.0 mM) and guest 8d 






Figure IV-S18. 1H NMR spectra (600 MHz, D2O, RT) recorded for a) host 1 (1.0 
mM), b) host 1 (1.0 mM) and guest 9d (1.0 mM), c) host 1 (1.0 mM) and guest 9d 






Figure IV-S19. 1H NMR spectra (600 MHz, D2O, RT) recorded for a) host 1 (1.0 
mM), b) host 1 (1.0 mM) and guest 10d (1.0 mM), c) host 1 (1.0 mM) and guest 10d 







Figure IV-S20. 1H NMR spectra (600 MHz, D2O, RT) recorded for a) host 1 (1.0 
mM), b) host 1 (1.0 mM) and guest 12d (1.0 mM), c) host 1 (1.0 mM) and guest 12d 






Figure IV-S21. 1H NMR spectra (600 MHz, D2O, RT) recorded for a) host 1 (1.0 
mM), b) host 1 (1.0 mM) and guest 12a (1.0 mM), c) host 1 (1.0 mM) and guest 12a 







Figure IV-S22. 1H NMR spectra (600 MHz, D2O, RT) recorded for a) host 1 (1.0 
mM), b) host 1 (1.0 mM) and guest 13a (1.0 mM), c) host 1 (1.0 mM) and guest 13a 






Figure IV-S23. 1H NMR spectra (600 MHz, D2O, RT) recorded for a) host 1 (1.0 
mM), b) host 1 (250 µM) and guest 19 (250 µM), c) host 1 (250 µM) and guest 19 






Figure IV-S24. 1H NMR spectra (600 MHz, D2O, RT) recorded for a) host 1 (1.0 
mM), b) host 1 (250 µM) and guest 20 (250 µM), c) host 1 (250 µM) and guest 20 







Figure IV-S25. 1H NMR spectra (600 MHz, D2O, RT) recorded for a) host 1 (1.0 
mM), b) host 1 (1.0 mM) and guest 22 (1.0 mM), c) host 1 (1.0 mM) and guest 22 







Figure IV-S26. 1H NMR spectra (600 MHz, D2O, RT) recorded for a) host 1 (1.0 
mM), b) host 1 (1.0 mM) and guest 23 (1.0 mM), c) host 1 (1.0 mM) and guest 23 




Isothermal Titration Calorimetry study of host 1 with selected guests  
 
 
Figure IV-S27. Isothermal Titration Calorimetry (ITC) curve obtained through direct 
binding titration studies. A solution of 1 (100 μM) in the cell was titrated with 5a 
(1.00 mM) in the syringe at 298.0 K in 20 mM sodium phosphate buffered water at 






Figure IV-S28. Isothermal Titration Calorimetry (ITC) curve obtained through 
competition binding studies. A solution of 1 (100 μM) and 5a (500 µM) in the cell 
was titrated with 6a (1.00 mM) in the syringe at 298.0 K in 20 mM sodium phosphate 






Figure IV-S29. Isothermal Titration Calorimetry (ITC) curve obtained through 
competition binding studies. A solution of 1 (100 μM) and 13a (500 µM) in the cell 
was titrated with 6b (1.00 mM) in the syringe at 298.0 K in 20 mM sodium phosphate 







Figure IV-S30. Isothermal Titration Calorimetry (ITC) curve obtained through 
competition binding studies. A solution of 1 (100 μM) and 13a (500 µM) in the cell 
was titrated with 6c (1.00 mM) in the syringe at 298.0 K in 20 mM sodium phosphate 







Figure IV-S31. Isothermal Titration Calorimetry (ITC) curve obtained through 
competition binding studies. A solution of 1 (100 μM) and 13a (2000 µM) in the cell 
was titrated with 6d (1.00 mM) in the syringe at 298.0 K in 20 mM sodium phosphate 







Figure IV-S32. Isothermal Titration Calorimetry (ITC) curve obtained through direct 
binding titration studies. A solution of 1 (10 μM) in the cell was titrated with 6Q (100 
µM) in the syringe at 298.0 K in 20 mM sodium phosphate buffered water at pH 7.4.  






Figure IV-S33. Isothermal Titration Calorimetry (ITC) curve obtained through 
competition binding studies. A solution of 1 (100 μM) and 13a (2000 µM) in the cell 
was titrated with 7d (1.00 mM) in the syringe at 298.0 K in 20 mM sodium phosphate 







Figure IV-S34. Isothermal Titration Calorimetry (ITC) curve obtained through 
competition binding studies. A solution of 1 (100 μM) and 13a (500 µM) in the cell 
was titrated with 8d (1.00 mM) in the syringe at 298.0 K in 20 mM sodium phosphate 







Figure IV-S35. Isothermal Titration Calorimetry (ITC) curve obtained through 
competition binding studies. A solution of 1 (100 μM) and 13a (500 µM) in the cell 
was titrated with 9d (1.00 mM) in the syringe at 298.0 K in 20 mM sodium phosphate 






Figure IV-S36. Isothermal Titration Calorimetry (ITC) curve obtained through 
competition binding studies. A solution of 1 (100 μM) and 13a (500 µM) in the cell 
was titrated with 10d (1.00 mM) in the syringe at 298.0 K in 20 mM sodium 







Figure IV-S37. Isothermal Titration Calorimetry (ITC) curve obtained through direct 
binding studies. A solution of 1 (100 µM) in the cell was titrated with 12a (1.00 mM) 
in the syringe at 298.0 K in 20 mM sodium phosphate buffered water at pH 7.4.  Ka = 







Figure IV-S38. Isothermal Titration Calorimetry (ITC) curve obtained through 
competition binding studies. A solution of 1 (50 μM) and 12d (1500 µM) in the cell 
was titrated with 6d (500 µM) in the syringe at 298.0 K in 20 mM sodium phosphate 






Figure IV-S39. Isothermal Titration Calorimetry (ITC) curve obtained through direct 
binding studies. A solution of 1 (10.0 µM) in the cell was titrated with 13a (100 µM) 
in the syringe at 298.0 K in 20 mM sodium phosphate buffered water at pH 7.4.  Ka = 






Figure IV-S40. Isothermal Titration Calorimetry (ITC) curve obtained through 
competition binding studies. A solution of 1 (100 μM) and 5a (500 µM) in the cell 
was titrated with 11a (1.00 mM) in the syringe at 298.0 K in 20 mM sodium 







Figure IV-S41. Isothermal Titration Calorimetry (ITC) curve obtained through 
competition binding studies. A solution of 1 (100 μM) and 5a (500 µM) in the cell 
was titrated with 11d (1.00 mM) in the syringe at 298.0 K in 20 mM sodium 






Figure IV-S42. Isothermal Titration Calorimetry (ITC) curve obtained through direct 
binding studies. A solution of 1 (100.0 µM) in the cell was titrated with 23 (1.00 mM) 
in the syringe at 298.0 K in 20 mM sodium phosphate buffered water at pH 7.4.  Ka = 







Figure IV-S43. Isothermal Titration Calorimetry (ITC) curve obtained through direct 
binding studies. A solution of 1 (100.0 µM) in the cell was titrated with 22 (1.00 mM) 
in the syringe at 298.0 K in 20 mM sodium phosphate buffered water at pH 7.4.  Ka = 








Figure IV-S44. Isothermal Titration Calorimetry (ITC) curve obtained through 
competition binding studies. A solution of 1 (100 µM) and 5a (500 µM) in the cell 
was titrated with 19 (1.00 mM) in the syringe at 298.0 K in 20 mM sodium phosphate 






Figure IV-S45. Isothermal Titration Calorimetry (ITC) curve obtained through 
competition binding studies. A solution of 1 (100 µM) and 13a (500 µM) in the cell 
was titrated with 20 (1.00 mM) in the syringe at 298.0 K in 20 mM sodium phosphate 






Figure IV-S46. Isothermal Titration Calorimetry (ITC) curve obtained through direct 
binding studies. A solution of 1 (80.0 µM) in the cell was titrated with 21 (500.0 µM) 
in the syringe at 298.0 K in 20 mM sodium phosphate buffered water at pH 7.4.  Ka = 






Figure IV-S47. Isothermal Titration Calorimetry (ITC) curve obtained through direct 
binding studies. A solution of 1 (30.0 µM) in the cell was titrated with 14 (300.0 µM) 
in the syringe at 298.0 K in 20 mM sodium phosphate buffered water at pH 7.4.  Ka = 






Figure IV-S48. Isothermal Titration Calorimetry (ITC) curve obtained through direct 
binding studies. A solution of 1 (30.0 µM) in the cell was titrated with 15 (300.0 µM) 
in the syringe at 298.0 K in 20 mM sodium phosphate buffered water at pH 7.4.  Ka = 






Figure IV-S49. Isothermal Titration Calorimetry (ITC) curve obtained through direct 
binding studies. A solution of 1 (100.0 µM) in the cell was titrated with 17 (1.00 mM) 
in the syringe at 298.0 K in 20 mM sodium phosphate buffered water at pH 7.4.  Ka = 






Figure IV-S50. Isothermal Titration Calorimetry (ITC) curve obtained through direct 
binding studies. A solution of 1 (100.0 µM) in the cell was titrated with 16 (1.00 mM) 
in the syringe at 298.0 K in 20 mM sodium phosphate buffered water at pH 7.4.  Ka = 






Figure IV-S51. Isothermal Titration Calorimetry (ITC) curve obtained through direct 
binding studies. A solution of 1 (30.0 µM) in the cell was titrated with 18 (300.00 
µM) in the syringe at 298.0 K in 20 mM sodium phosphate buffered water at pH 7.4.  




Single crystal X-ray data for host 1 and guest 6a and 6d 
 
 
     
Figure IV-S52. Top view and side view of X-ray single crystal structure of host 1 and 











Figure IV-S53. Top view and side view of X-ray single crystal structure of host 1 and 
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